This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Haemorrhage, not elsewhere classified
R18_HAEMORRHAGE_NOT_ELSEW_CLASSIFIED
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
1386 |
4. Check minimum number of eventsNone |
1386 |
5. Include endpointsNone |
1386 |
6. Filter based on genotype QC (FinnGen only) |
1386 |
Control definitions (FinnGen only)
- Control exclude
- R18_GENERAL_SYMPTOMS_SIGNS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R[5-6]
- Name in latin
- Haemorrhagia non alibi classificata
Similar endpoints
↥List of similar endpoints to
Haemorrhage, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- General symptoms and signs
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 1386 | 669 | 717 |
| Unadjusted period prevalence (%) | 0.27 | 0.23 | 0.32 |
| Median age at first event (years) | 70.77 | 69.90 | 71.58 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1189
- Matched controls
- 11889
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R58
ICD-10 Finland
Haemorrhage, not elsewhere classified
+∞
323.0
1189
18
B01AA03
ATC
warfarin; systemic
4.9
126.7
549
1769
C03CA01
ATC
furosemide; systemic
4.3
116.8
633
2488
R50.9
ICD-10 Finland
Fever, unspecified
12.6
108.7
204
192
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.5
91.0
710
3528
R55
ICD-10 Finland
Syncope and collapse
21.9
90.8
135
69
I48
ICD-10 Finland
Atrial fibrillation and flutter
3.7
85.7
513
2035
R53
ICD-10 Finland
Malaise and fatigue
4.7
72.7
281
732
I50.9
ICD-10 Finland
Heart failure, unspecified
4.1
72.0
330
1013
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.2
72.0
325
984
B01AB05
ATC
enoxaparin; parenteral
3.2
69.7
516
2310
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.6
68.9
269
704
R56.8
ICD-10 Finland
Other and unspecified convulsions
188.5
68.8
71
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.2
67.5
473
2025
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.8
62.5
318
1053
AA1AD
NOMESCO Finland
CT of head and brain
3.3
60.9
388
1527
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
4.7
60.4
229
575
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
3.5
59.8
337
1205
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
5.1
56.5
194
436
R51.80
ICD-10 Finland
Headache
7.3
55.5
141
216
TPH04
NOMESCO Finland
Cathetrisation of vein
3.3
55.5
348
1339
XF400
NOMESCO Finland
ECG with 12 standard connections
3.5
53.9
303
1070
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
5.8
53.6
162
313
A02BC02
ATC
pantoprazole; systemic
2.6
52.0
819
5445
C07AB07
ATC
bisoprolol; oral
2.5
51.5
697
4247
R60.0
ICD-10 Finland
Localized oedema
4.8
51.3
188
451
R06.0
ICD-10 Finland
Dyspnoea
2.9
49.5
386
1698
N02BE01
ATC
paracetamol; systemic, rectal
3.3
47.9
1046
8221
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.2
47.9
200
544
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
47.4
451
2229
H02AB06
ATC
prednisolone; systemic
2.5
47.0
608
3550
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.8
46.3
385
1752
N02AA05
ATC
oxycodone; systemic
3.4
46.0
261
917
N02AX02
ATC
tramadol; systemic, rectal
2.5
45.9
569
3236
R04.0
ICD-10 Finland
Epistaxis
4.6
45.7
173
427
J01DB01
ATC
cefalexin; oral
2.8
45.1
977
7420
207
Kela drug reimbursment
Chronic arrhythmias
3.1
44.9
298
1166
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.9
44.7
342
1473
D64.9
ICD-10 Finland
Anaemia, unspecified
3.7
44.2
213
655
A46
ICD-10 Finland
Erysipelas
3.4
43.8
248
865
I50.0
ICD-10 Finland
Congestive heart failure
4.2
42.9
176
468
S18
ICPC
Laceration/cut
2.4
42.2
570
3335
TPH07
NOMESCO Finland
Cathetrisation of artery
3.6
41.3
205
644
M79.6
ICD-10 Finland
Pain in limb
2.4
40.9
459
2436
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
2.6
40.7
365
1712
C03DA01
ATC
spironolactone; oral
3.6
40.6
208
669
WX892
NOMESCO Finland
Monitored bed care
4.4
40.2
156
392
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.7
39.6
189
573
K78
ICPC
Atrial fibrillation/flutter
3.8
38.6
182
546
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.0
38.4
131
288
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.8
36.5
276
1158
R4110
NOMESCO Finland
Physiotherapy
2.5
36.3
374
1872
N03AX16
ATC
pregabalin; oral
2.6
36.1
310
1403
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
4.4
34.7
134
334
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.5
34.7
176
558
UJF32
NOMESCO Finland
Coloscopy
2.4
34.6
369
1869
R07.4
ICD-10 Finland
Chest pain, unspecified
2.4
34.1
362
1828
WW500
NOMESCO Finland
Blood transfusion
6.5
33.9
91
149
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
4.1
33.9
140
372
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
11.4
33.8
64
59
C01AA05
ATC
digoxin; systemic
3.3
33.7
192
664
K92.1
ICD-10 Finland
Melaena
4.6
33.3
121
283
ZX120
NOMESCO Finland
Intravenous
3.6
33.0
161
493
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
2.8
33.0
244
1003
N02AJ06
ATC
codeine and paracetamol; systemic
2.2
32.8
441
2488
J01MA12
ATC
levofloxacin; systemic
2.7
32.8
269
1177
A11CC03
ATC
alfacalcidol; systemic
9.9
31.9
65
69
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.3
31.9
366
1909
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
4.2
31.8
127
326
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
4.4
31.7
120
293
TK800
NOMESCO Finland
Hemodialysis
9.9
31.4
64
68
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.7
31.4
244
1030
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.8
31.3
233
959
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
6.7
31.3
82
130
WX110
NOMESCO Finland
Local anesthesy
2.1
31.2
764
5520
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.1
31.1
542
3405
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
7.6
30.9
74
103
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.2
30.8
400
2204
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.0
30.8
131
356
B01AF02
ATC
apixaban; oral
3.1
30.5
185
666
J01FF01
ATC
clindamycin; systemic
2.3
30.4
346
1790
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
14.7
30.4
51
36
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
30.3
360
1900
B01AB10
ATC
tinzaparin; parenteral
4.0
30.1
128
348
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
5.0
30.0
101
218
M04AA01
ATC
allopurinol; systemic
2.7
29.4
224
932
M10.9
ICD-10 Finland
Gout, unspecified
3.8
28.4
129
371
I10
ICD-10 Finland
Essential (primary) hypertension
2.0
28.3
767
5655
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
28.3
132
389
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
6.2
28.2
78
133
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
5.3
28.0
88
176
JN4BD
NOMESCO Finland
Extensive body CT
3.0
27.7
172
627
JN3AD
NOMESCO Finland
Abdominal CT examination
3.6
27.7
131
390
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.8
27.6
193
760
R11
ICD-10 Finland
Nausea and vomiting
3.8
27.4
121
340
A28
ICPC
Limited function/disability NOS
2.5
27.3
247
1128
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
30.9
27.3
36
12
AN1
HP
Coronary angiography
2.7
27.3
207
856
L28
ICPC
Limited function/disability (L)
2.5
27.1
244
1112
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
4.2
27.0
108
277
Z49.1
ICD-10 Finland
Extracorporeal dialysis
12.8
26.5
47
38
C08CA01
ATC
amlodipine; oral
2.0
26.5
494
3125
WX872
NOMESCO Finland
Intensive care
4.1
25.7
104
270
S97
ICPC
Chronic ulcer skin
4.0
25.4
106
283
WX882
NOMESCO Finland
High dependency care
6.5
25.3
67
108
R60.9
ICD-10 Finland
Oedema, unspecified
5.6
25.3
76
144
TKC20
NOMESCO Finland
Catheterisation of bladder
3.3
25.2
135
442
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
7.6
25.2
60
83
TFP20
NOMESCO Finland
Cardiodefibrillation
3.2
25.2
141
477
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.9
24.9
167
637
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
3.7
24.9
115
335
V03AE02
ATC
sevelamer; oral
71.4
24.9
28
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
5.1
24.6
79
162
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
24.5
422
2565
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
24.3
270
1358
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
6.7
24.3
63
99
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.3
24.2
253
1237
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.4
24.2
228
1057
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.6
24.2
198
852
WX002
NOMESCO Finland
Sedation and analgesia
2.3
24.0
268
1353
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.8
23.9
82
181
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.6
23.6
85
197
I49.5
ICD-10 Finland
Sick sinus syndrome
4.6
23.6
85
197
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
34.1
23.4
30
9
N18.0
ICD-10 Finland
End-stage renal disease
13.7
23.3
40
30
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.3
22.5
120
391
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.0
22.5
393
2386
A06AD11
ATC
lactulose; oral
2.4
22.5
211
976
SPAT1263
SPAT
Sampling
1.9
22.3
507
3383
J01MA02
ATC
ciprofloxacin; systemic
1.9
22.3
473
3082
A02BC05
ATC
esomeprazole; systemic
1.9
22.3
455
2923
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.5
22.2
199
897
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.3
22.2
236
1161
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
2.0
22.1
335
1919
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.6
22.1
182
781
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
3.1
22.0
127
438
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.3
22.0
226
1091
R31
ICD-10 Finland
Unspecified haematuria
2.7
21.9
163
661
B03XA02
ATC
darbepoetin alfa; parenteral
8.4
21.8
48
59
A04
ICPC
Weakness/tiredness general
2.6
21.7
174
735
B01AC04
ATC
clopidogrel; oral
2.3
21.7
237
1179
SPAT1254
SPAT
Administration of medicine
2.4
21.6
205
951
JN4AD
NOMESCO Finland
Body CT examination
3.3
21.6
112
358
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
12.6
21.4
38
31
FPE00
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with ventricular electrode
6.5
21.3
56
90
A10
ICPC
Bleeding/haemorrhage NOS
18.2
20.9
32
18
N05CF01
ATC
zopiclone; oral
1.9
20.7
407
2565
I80.29
ICD-10 Finland
Phlebitis and thrombophlebitis of other deep vessels of lower extremities
5.3
20.6
64
127
V03AE01
ATC
polystyrene sulfonate; oral
10.3
20.4
40
40
C01DA14
ATC
isosorbide mononitrate; oral
2.1
20.4
254
1336
XF404
NOMESCO Finland
Ambulatory ECG
2.8
20.4
141
546
Z45.0
ICD-10 Finland
Adjustment and management of cardiac devices
4.0
20.4
83
217
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.9
20.3
395
2473
B01AB04
ATC
dalteparin; parenteral
3.6
20.0
93
272
J01CA04
ATC
amoxicillin; systemic
1.9
19.9
879
7184
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.4
19.8
187
862
N03AX12
ATC
gabapentin; oral
2.4
19.8
179
806
Y57
ICD-10 Finland
Adverse effects in the therapeutic use of other and unspecified drugs and medicaments
8.8
19.7
42
49
C07AB02
ATC
metoprolol; systemic
2.0
19.7
301
1720
L04AA06
ATC
mycophenolic acid; systemic
10.0
19.7
39
40
Z71.8
ICD-10 Finland
Other specified counselling
2.1
19.6
260
1400
Z49.0
ICD-10 Finland
Preparatory care for dialysis
19.8
19.6
29
15
A07AA02
ATC
nystatin; oral
3.4
19.5
99
311
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.6
19.5
147
601
A12AA04
ATC
calcium carbonate; oral
9.4
19.4
40
44
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.1
19.4
114
396
SPAT1255
SPAT
Intravenous administration of medicine
3.4
19.2
98
309
X59
ICD-10 Finland
Exposure to unspecified factor
2.2
19.2
214
1068
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.8
19.1
524
3664
I87.2
ICD-10 Finland
Venous insufficiency (chronic)(peripheral)
2.7
19.1
138
550
UKC02
NOMESCO Finland
Cystoscopy
2.2
19.1
230
1191
ZXA00
NOMESCO Finland
Right side
1.9
19.0
350
2140
A41.9
ICD-10 Finland
Sepsis, unspecified
4.9
18.9
63
135
E0000UV
ATC
NA
1.8
18.8
427
2803
R52.9
ICD-10 Finland
Pain, unspecified
3.4
18.6
94
294
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.8
18.6
437
2902
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.9
18.5
347
2134
SPAT1216
SPAT
Assessment of functional ability
2.2
18.4
215
1093
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.6
18.4
64
144
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
3.0
18.4
114
412
J45.9
ICD-10 Finland
Asthma, unspecified
2.2
18.2
208
1050
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
7.1
18.0
44
64
N06AX11
ATC
mirtazapine; oral
1.9
18.0
345
2131
N18.8
ICD-10 Finland
Other chronic renal failure
5.0
17.9
58
121
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.2
17.9
207
1047
196
Kela drug reimbursment
Paricalcitol and cinacalcet
27.2
17.8
24
9
R02
ICPC
Shortness of breath/dyspnoea
2.5
17.8
152
664
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
2.2
17.8
203
1023
127
Kela drug reimbursment
Transplant complication
11.3
17.8
33
30
I83.0
ICD-10 Finland
Varicose veins of lower extremities with ulcer
5.7
17.7
51
93
205
Kela drug reimbursment
Chronic hypertension
1.8
17.7
401
2621
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
2.1
17.5
234
1257
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.1
17.5
232
1246
J01MA14
ATC
moxifloxacin; systemic
2.9
17.4
113
421
A08
ICPC
Swelling
4.0
17.3
71
187
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.5
17.3
143
615
R00.1
ICD-10 Finland
Bradycardia, unspecified
4.1
17.2
67
169
J01AA02
ATC
doxycycline; systemic
1.8
17.1
851
7007
Z95.2
ICD-10 Finland
Presence of prosthetic heart valve
4.9
17.1
56
118
L17
ICPC
Foot/toe symptom/complaint
1.9
17.0
300
1793
Z94.0
ICD-10 Finland
Kidney transplant status
13.5
17.0
29
22
N19
ICD-10 Finland
Unspecified kidney failure
4.2
17.0
65
161
R04.2
ICD-10 Finland
Haemoptysis
4.1
16.9
67
171
TPX10
NOMESCO Finland
Implantation of vascular injection port
5.4
16.9
51
98
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
3.4
16.9
84
260
K92.0
ICD-10 Finland
Haematemesis
5.1
16.7
53
108
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.0
16.7
101
359
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
16.7
172
826
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
16.6
16.6
26
16
B03XA01
ATC
erythropoietin; parenteral
13.6
16.5
28
21
RS221
NOMESCO Finland
NA
8.8
16.5
35
41
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.7
16.5
120
480
N05AH04
ATC
quetiapine; oral
2.3
16.4
161
754
S06.0
ICD-10 Finland
Concussion
2.6
16.4
123
500
R03AC02
ATC
salbutamol; inhalant
1.7
16.4
541
3937
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.9
16.3
284
1687
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.1
16.3
64
162
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.2
16.3
87
284
3AC01
NOMESCO Finland
NA
11.4
16.3
30
27
GD1AD
NOMESCO Finland
Thorax CT examination
3.8
16.2
69
188
EBA15
NOMESCO Finland
Extraction of large number of teeth
4.3
16.2
61
149
Z49.2
ICD-10 Finland
Other dialysis
30.5
16.1
21
7
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.6
16.1
126
523
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
48.2
16.0
19
*
A01
ICPC
Pain general/multiple sites
2.8
16.0
105
392
I80.3
ICD-10 Finland
Phlebitis and thrombophlebitis of lower extremities, unspecified
3.9
16.0
67
180
NF1AA
NOMESCO Finland
Hip X-ray examination
2.5
16.0
129
546
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.6
15.9
125
520
WX722
NOMESCO Finland
PEEP
3.5
15.8
74
219
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.8
15.7
359
2332
ZXA05
NOMESCO Finland
Left side
1.8
15.6
320
2006
R42
ICD-10 Finland
Dizziness and giddiness
1.9
15.6
250
1436
E87.5
ICD-10 Finland
Hyperkalaemia
7.3
15.6
37
52
J01FA06
ATC
roxithromycin; oral
1.7
15.4
431
2974
SPAT1301
SPAT
No procedures
1.7
15.4
391
2621
A02BC01
ATC
omeprazole; systemic
1.8
15.4
328
2082
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.9
15.3
272
1623
B05DA
ATC
Isotonic solutions
29.0
15.2
20
7
M54.5
ICD-10 Finland
Low back pain
1.8
15.2
319
2013
C09AA05
ATC
ramipril; oral
1.8
15.2
338
2174
W19
ICD-10 Finland
Unspecified fall
2.5
15.2
127
548
G47.3
ICD-10 Finland
Sleep apnoea
2.0
15.2
217
1195
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
23.7
15.1
21
9
N06AX21
ATC
duloxetine; oral
2.7
15.0
104
403
UJF30
NOMESCO Finland
Ileoscopy through colon
2.6
15.0
116
477
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.8
15.0
349
2277
K29
ICPC
Cardiovascular sympt/complt other
3.6
14.9
69
202
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
7.7
14.9
34
45
R03BB04
ATC
tiotropium bromide; inhalant
2.4
14.9
134
600
X58
ICD-10 Finland
Exposure to other specified factors
2.3
14.8
152
724
I35.0
ICD-10 Finland
Aortic (valve) stenosis
2.6
14.7
109
440
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
2.2
14.7
158
771
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
3.3
14.7
75
238
PBU84
NOMESCO Finland
Plastic repair of arteriovenous fistula from artery of upper extremity
+∞
14.6
14
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
8.6
14.5
31
37
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
3.7
14.5
63
176
I50
ICD-10 Finland
Heart failure
3.8
14.4
62
171
XF600
NOMESCO Finland
Bloodpressure measurement
2.9
14.3
88
317
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
4.3
14.3
53
128
PWE00
NOMESCO Finland
Reoperation for deep haemorrhage in surgery of peripheral vessels and lymphatic system
27.5
14.3
19
7
NK1XE
NOMESCO Finland
Other ultrasound examinnation of muscle or tendon
10.6
14.3
27
26
E66.01
ICD-10 Finland
Obesity due to excess calories
3.0
14.2
86
305
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
9.9
14.2
28
29
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.1
14.2
172
886
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.6
14.1
103
413
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
2.8
14.0
94
357
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.4
13.9
122
539
137
Kela drug reimbursment
Uraemia requiring dialysis
17.8
13.9
21
12
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
54.0
13.8
16
*
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
20.3
13.8
20
10
TK810
NOMESCO Finland
Hemofiltration
20.3
13.8
20
10
N03AX14
ATC
levetiracetam; systemic
6.5
13.7
35
55
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
5.3
13.7
41
79
E000001
ATC
NA
1.9
13.6
228
1328
79199
ICD-8 Finland
Headache
+∞
13.6
13
*
B05DB
ATC
Hypertonic solutions
34.4
13.5
17
5
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.6
13.4
46
103
A03FA01
ATC
metoclopramide; systemic, rectal
1.9
13.4
216
1240
TQW11
NOMESCO Finland
Vacuum treatment of wound
6.0
13.4
36
61
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.7
13.3
93
360
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
2.3
13.3
128
591
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
3.0
13.3
77
267
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.0
13.3
187
1021
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.6
13.2
59
169
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.9
13.1
84
308
C08CA02
ATC
felodipine; oral
2.2
13.1
141
686
N06AX16
ATC
venlafaxine; oral
2.3
13.1
122
556
WX402
NOMESCO Finland
General anaesthesia
2.0
13.1
177
949
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
13.0
300
1935
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
2.2
13.0
138
670
P01AB01
ATC
metronidazole; oral, rectal
1.7
12.9
387
2688
TFC00
NOMESCO Finland
Catheterisation of right atrium or ventricle
5.8
12.9
36
64
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.6
12.9
95
383
K99
ICPC
Cardiovascular disease other
4.0
12.8
51
132
D68.3
ICD-10 Finland
Haemorrhagic disorder due to circulating anticoagulants
14.2
12.8
21
15
C01BD01
ATC
amiodarone; systemic
3.7
12.8
56
158
I95.9
ICD-10 Finland
Hypotension, unspecified
9.1
12.8
26
29
I83.1
ICD-10 Finland
Varicose veins of lower extremities with inflammation
4.9
12.8
41
86
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
2.7
12.7
86
329
M25.5
ICD-10 Finland
Pain in joint
1.8
12.7
271
1707
R23.3
ICD-10 Finland
Spontaneous ecchymoses
4.7
12.7
42
91
SAA01
NOMESCO Finland
Simple examination of mouth
1.6
12.6
684
5510
I48.9
ICD-10 Finland
Atrial fibrillation and atrial flutter, unspecified
2.8
12.6
85
323
N30.0
ICD-10 Finland
Acute cystitis
2.1
12.6
156
806
R07.3
ICD-10 Finland
Other chest pain
2.4
12.6
110
483
PG1QT
NOMESCO Finland
Very extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
32.4
12.6
16
5
PG1NT
NOMESCO Finland
Endovascular embolisation for bleeding with radiological guidance not elsewhere classified
32.4
12.6
16
5
L04AD01
ATC
ciclosporin; systemic
6.7
12.5
31
47
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
8.8
12.5
26
30
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
2.6
12.5
95
387
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.9
12.5
78
285
EBA00
NOMESCO Finland
Extraction of tooth
1.7
12.4
332
2233
T88.7
ICD-10 Finland
Unspecified adverse effect of drug or medicament
7.0
12.4
30
44
SPAT1229
SPAT
Assessment of need for aid
2.4
12.4
112
502
XW000
NOMESCO Finland
Bone marrow biopsy
3.4
12.4
59
178
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.4
12.4
110
490
R52.2
ICD-10 Finland
Other chronic pain
5.1
12.4
38
76
N05BA04
ATC
oxazepam; oral
1.8
12.3
263
1654
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.6
12.3
88
349
I50.1
ICD-10 Finland
Left ventricular failure
2.8
12.1
79
296
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
21.5
12.0
17
8
ZZA00
NOMESCO Finland
Split skin graft
3.6
12.0
53
151
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.8
11.8
77
287
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
3.8
11.8
50
137
I20.99
ICD-10 Finland
Angina pectoris, unspecified
2.4
11.8
98
421
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
7.1
11.8
28
40
R33
ICD-10 Finland
Retention of urine
2.4
11.8
106
475
C09AA02
ATC
enalapril; systemic
1.7
11.8
263
1672
T14.5
ICD-10 Finland
Injury of blood vessel(s) of unspecified body region
10.6
11.8
22
21
R13
ICD-10 Finland
Dysphagia
2.8
11.8
77
289
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.7
11.8
51
143
J01DA01
ATC
[U] cefalexin; systemic
1.5
11.7
656
5282
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
2.2
11.7
125
608
H05BX01
ATC
cinacalcet; oral
16.6
11.7
18
11
SPAT1260
SPAT
Consultation of another employee
1.8
11.7
209
1241
RS222
NOMESCO Finland
NA
7.0
11.7
28
41
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.8
11.6
49
134
B01AF01
ATC
rivaroxaban; oral
2.0
11.6
157
839
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.0
11.6
66
225
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
3.1
11.6
63
210
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.2
11.6
61
199
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
3.3
11.6
57
177
SPAT1249
SPAT
Treatment-related counselling outside office
1.6
11.6
440
3232
N17
ICPC
Vertigo/dizziness
2.1
11.6
130
645
I20.09
ICD-10 Finland
Unstable angina
2.6
11.6
83
329
RS220
NOMESCO Finland
NA
7.2
11.5
27
38
H02AB07
ATC
prednisone; oral
2.0
11.5
160
867
B02AA02
ATC
tranexamic acid; systemic
2.1
11.5
138
704
Y84
ICD-10 Finland
Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.6
11.5
26
35
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.7
11.4
286
1879
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.4
11.4
101
450
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
6.1
11.4
30
50
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
2.1
11.4
137
699
ZXA10
NOMESCO Finland
Bilateral
1.8
11.3
230
1418
C10AA01
ATC
simvastatin; oral
1.5
11.3
543
4206
SPAT1262
SPAT
Handing over of treatment supplies
1.8
11.3
220
1339
G44.2
ICD-10 Finland
Tension-type headache
2.2
11.2
112
528
R69
ICD-10 Finland
Unknown and unspecified causes of morbidity
20.2
11.1
16
8
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
7.2
11.1
26
37
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
11.1
47
130
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.5
11.0
87
365
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.0
10.9
43
111
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
10.9
267
1739
S80.1
ICD-10 Finland
Contusion of other and unspecified parts of lower leg
3.8
10.9
45
121
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
3.4
10.9
53
163
R4120
NOMESCO Finland
Occupational therapy
2.7
10.9
76
297
WZC30
NOMESCO Finland
Teaching
2.0
10.9
140
735
WW200
NOMESCO Finland
Immunization
4.1
10.9
41
102
Z02.7
ICD-10 Finland
Issue of medical certificate
2.7
10.9
72
273
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
2.4
10.9
89
381
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
4.4
10.9
38
88
WX730
NOMESCO Finland
Conventional respirator
5.1
10.8
33
66
PH1AC
NOMESCO Finland
Flebography of over extremity with X-ray
5.9
10.8
29
50
N06AB04
ATC
citalopram; systemic
1.8
10.7
220
1362
SPAT1211
SPAT
Application of soft bandage
2.2
10.7
115
558
R5140
NOMESCO Finland
Monitoring the use of the aid
2.2
10.7
108
511
81
HP
Angiography of the heart and coronary arteries
2.4
10.7
95
422
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
3.6
10.6
47
135
I34.00
ICD-10 Finland
Mitral (valve) incompetence NOS or of specified cause, except rheumatic
4.2
10.6
39
95
C03AA03
ATC
hydrochlorothiazide; oral
2.1
10.5
129
664
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.3
10.5
38
91
EBA10
NOMESCO Finland
Surgical removal of tooth
2.2
10.5
109
521
I36.1
ICD-10 Finland
Nonrheumatic tricuspid (valve) insufficiency
5.7
10.4
29
52
E66.00
ICD-10 Finland
Metabolic syndrome
2.9
10.4
64
230
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.9
10.4
62
221
UDQ12
NOMESCO Finland
Flexible laryngoscopy
2.7
10.3
69
263
V03AE03
ATC
lanthanum carbonate; oral
32.8
10.3
13
*
I48.0
ICD-10 Finland
Paroxysmal atrial fibrillation
2.5
10.3
82
345
PB1DE
NOMESCO Finland
Upper extremity arteries ultrasound examination with Doppler method
23.6
10.2
14
6
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.1
10.2
116
577
A29
ICPC
General symptom/complaint other
2.1
10.2
123
631
379
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism
4.7
10.2
33
71
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
2.3
10.2
90
401
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.4
10.2
82
349
L60.0
ICD-10 Finland
Ingrowing nail
3.1
10.1
54
179
SPAT1234
SPAT
Support of social functional capacity
2.7
10.1
67
254
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.8
10.1
179
1058
B01AE07
ATC
dabigatran etexilate; oral
2.9
10.1
62
223
K02.1
ICD-10 Finland
Caries of dentine
1.5
10.1
530
4156
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
4.4
10.1
35
81
I35.1
ICD-10 Finland
Aortic (valve) insufficiency
2.5
10.0
75
307
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.8
10.0
63
233
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
2.6
9.9
74
301
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.9
9.9
59
210
S16
ICPC
Bruise/contusion
3.1
9.9
53
176
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
3.2
9.9
51
165
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.2
9.9
51
165
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
16.9
9.9
15
9
N03AF02
ATC
oxcarbazepine; oral
4.5
9.9
34
78
L04AA01
ATC
[U] ciclosporin; systemic
6.0
9.8
26
44
R52.0
ICD-10 Finland
Acute pain
5.5
9.8
28
52
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
26.2
9.8
13
5
Z04.9
ICD-10 Finland
Examination and observation for unspecified reason
2.9
9.8
57
200
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
2.2
9.7
99
469
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
9.7
514
4025
K74.6
ICD-10 Finland
Other and unspecified cirrhosis of liver
7.4
9.7
22
30
Z00.0
ICD-10 Finland
General medical examination
1.7
9.7
200
1235
X57
ICD-10 Finland
Unspecified privation
4.3
9.7
35
84
R05
ICPC
Cough
1.7
9.7
220
1399
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
3.6
9.7
42
119
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
13.5
9.7
16
12
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
55.4
9.7
11
*
R59.1
ICD-10 Finland
Generalized enlarged lymph nodes
55.4
9.7
11
*
JAH01
NOMESCO Finland
Laparoscopy
3.3
9.6
47
146
UJD02
NOMESCO Finland
Gastroscopy
2.7
9.6
66
257
R03DC03
ATC
montelukast; oral
1.9
9.6
147
822
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
8.5
9.6
20
24
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
2.0
9.6
122
638
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.7
9.6
40
110
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
4.7
9.5
31
67
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
7.2
9.5
22
31
SPAT1310
SPAT
Counselling related to known health issue
1.5
9.5
351
2535
NF3AA
NOMESCO Finland
Femur X-ray examination
4.2
9.5
35
86
T90
ICPC
Diabetes non-insulin dependent
1.6
9.5
263
1767
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
2.9
9.5
56
199
D07AB08
ATC
desonide; topical
2.1
9.5
115
589
L14
ICPC
Leg/thigh symptom/complaint
2.3
9.5
88
402
SPAT1153
SPAT
Removal of sutures
1.5
9.4
354
2562
212
Kela drug reimbursment
Gout
4.2
9.4
34
82
A12BA01
ATC
potassium chloride; oral
2.5
9.4
73
303
G40.9
ICD-10 Finland
Epilepsy, unspecified
4.1
9.4
35
87
A04AA01
ATC
ondansetron; systemic, rectal
2.5
9.4
70
285
2BD01
NOMESCO Finland
NA
21.9
9.4
13
6
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
21.9
9.4
13
6
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.8
9.3
163
957
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.5
9.3
71
294
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.6
9.3
66
261
I82.88
ICD-10 Finland
Embolism and thrombosis of other specified veins
5.1
9.3
28
56
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
2.5
9.3
72
298
RD210
NOMESCO Finland
NA
5.3
9.2
27
52
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
2.2
9.2
92
435
J01CE02
ATC
phenoxymethylpenicillin; oral
1.5
9.2
687
5745
D69.9
ICD-10 Finland
Haemorrhagic condition, unspecified
13.8
9.2
15
11
KA1AE
NOMESCO Finland
Kidney ultrasound examination
3.7
9.2
38
104
Z51.5
ICD-10 Finland
Palliative care
2.4
9.1
80
353
L04AX01
ATC
azathioprine; systemic
3.1
9.1
48
158
L03.0
ICD-10 Finland
Cellulitis of finger and toe
2.4
9.1
75
322
I25.2
ICD-10 Finland
Old myocardial infarction
2.1
9.1
100
492
C09CA06
ATC
candesartan; oral
1.7
9.1
219
1414
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
6.3
9.1
23
37
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
2.7
9.1
62
241
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
2.8
9.1
58
217
H02AB04
ATC
methylprednisolone; systemic
1.8
9.1
152
881
N06AB10
ATC
escitalopram; oral
1.8
9.0
165
979
S30.0
ICD-10 Finland
Contusion of lower back and pelvis
3.3
9.0
43
132
M13.9
ICD-10 Finland
Arthritis, unspecified
2.3
9.0
80
358
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.5
9.0
413
3123
R06
ICPC
Nose bleed/epistaxis
4.2
9.0
33
81
FN1YT
NOMESCO Finland
Percutaneous insertion of coronary artery stent
2.4
9.0
79
349
XG410
NOMESCO Finland
Flow-volume spirometry
2.8
9.0
56
204
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.7
9.0
38
106
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
18.7
8.9
13
7
SPAT1097
SPAT
Recording of ECG
1.8
8.9
174
1057
J04AB02
ATC
rifampicin; systemic
5.8
8.9
24
42
ECB00
NOMESCO Finland
Suture of gingiva
3.1
8.9
48
161
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
8.9
129
710
C07AG02
ATC
carvedilol; oral
2.3
8.9
79
353
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.1
8.9
46
150
D07AC01
ATC
betamethasone; topical
1.5
8.9
348
2537
PEC23
NOMESCO Finland
Suture of common femoral artery
12.6
8.9
15
12
N03AX09
ATC
lamotrigine; oral
3.8
8.9
36
97
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
8.9
100
497
K05.31
ICD-10 Finland
Periodontitis pronounced
2.0
8.9
115
607
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
3.3
8.8
43
134
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
6.4
8.8
22
35
C08CA13
ATC
lercanidipine; oral
1.8
8.8
161
958
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
8.7
265
1818
K12.10
ICD-10 Finland
Stomatitis NOS
14.1
8.7
14
10
R52.1
ICD-10 Finland
Chronic intractable pain
50.3
8.7
10
*
WX203
NOMESCO Finland
Infraclavicular plexus blockade
4.0
8.7
33
84
R06AE07
ATC
cetirizine; oral
1.5
8.7
397
2995
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
5.1
8.7
26
52
I48.2
ICD-10 Finland
Chronic atrial fibrillation
3.2
8.6
44
142
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.3
8.6
75
332
JN4CD
NOMESCO Finland
Very extensive body CT
2.8
8.6
54
197
R5110
SPAT
NA
3.5
8.6
38
110
W22
ICD-10 Finland
Striking against or struck by other object(s)
2.6
8.6
62
248
I20.00
ICD-10 Finland
Unstable angina
3.0
8.6
49
169
-50
ICPC
Medication/prescr/renewal
2.7
8.6
55
206
I11.0
ICD-10 Finland
Hypertensive heart disease with (congestive) heart failure
3.3
8.6
42
132
J02AC01
ATC
fluconazole; systemic
1.5
8.5
334
2433
JAH00
NOMESCO Finland
Laparotomy
3.2
8.5
43
138
PD5AD
NOMESCO Finland
CT of aorta
5.0
8.5
26
53
SPAT1231
SPAT
Assessment of adjustments needed in living environment
4.2
8.5
31
76
A03
ICPC
Fever
1.9
8.5
131
737
FKD00
NOMESCO Finland
Replacement of mitral valve using mechanical prosthesis
20.2
8.5
12
6
PD5BD
NOMESCO Finland
Extensive CT of aorta
3.9
8.5
33
86
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.8
8.5
53
194
A41.8
ICD-10 Finland
Other specified sepsis
5.7
8.5
23
41
B34.9
ICD-10 Finland
Viral infection, unspecified
4.4
8.5
29
67
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
8.4
595
4889
RJ521
NOMESCO Finland
NA
90.6
8.4
9
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
3.7
8.4
35
97
321
Kela drug reimbursment
Paricalcitol and cinacalcet
12.9
8.4
14
11
L12
ICPC
Hand/finger symptom/complaint
1.8
8.4
134
764
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.7
8.4
182
1143
XCW99
NOMESCO Finland
Other investigative procedure of eye
1.9
8.4
128
717
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
3.4
8.3
38
113
7840A
ICD-9 Finland
Symptoms involving head and neck, Headache
+∞
8.3
8
*
G04CA02
ATC
tamsulosin; oral
1.6
8.3
277
1940
E87.6
ICD-10 Finland
Hypokalaemia
3.2
8.3
42
135
WX202
NOMESCO Finland
Supraclavicular plexus blockade
6.3
8.3
21
34
K77
ICPC
Heart failure
3.6
8.3
36
103
C07AA05
ATC
propranolol; systemic
1.7
8.3
173
1070
SAA03
NOMESCO Finland
Extended examination of mouth
1.5
8.3
351
2598
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.6
8.3
270
1886
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
3.2
8.2
42
136
R41.0
ICD-10 Finland
Disorientation, unspecified
3.5
8.2
37
109
J01EA01
ATC
trimethoprim; systemic
1.6
8.2
268
1869
SPAT1312
SPAT
General health counselling
1.5
8.2
338
2485
F10.20
ICD-10 Finland
Alcohol dependence currently independent
5.0
8.2
25
51
M10
ICD-10 Finland
Gout
2.5
8.2
60
243
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.2
8.2
82
389
I95.1
ICD-10 Finland
Orthostatic hypotension
3.1
8.2
42
137
A02BA02
ATC
ranitidine; systemic
1.6
8.2
217
1438
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
4.7
8.1
26
56
SPAT1139
SPAT
Nutrition survey
3.2
8.1
41
132
E66.9
ICD-10 Finland
Obesity, unspecified
3.3
8.1
38
116
N30.9
ICD-10 Finland
Cystitis, unspecified
2.4
8.1
65
276
C10AA05
ATC
atorvastatin; oral
1.5
8.1
436
3388
NFM10
NOMESCO Finland
Fasciotomy of thigh
33.6
8.1
10
*
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
17.3
8.1
12
7
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
6.9
8.1
19
28
K22.6
ICD-10 Finland
Gastro-oesophageal laceration-haemorrhage syndrome
9.0
8.0
16
18
TK820
NOMESCO Finland
Peritoneal dialysis
22.2
8.0
11
5
FFW96
NOMESCO Finland
Other operation on atria
22.2
8.0
11
5
TQW99
NOMESCO Finland
Other minor procedure on skin
2.5
8.0
62
259
FPE20
NOMESCO Finland
Implantation of transvenous cardiac pacemaker with atrial and ventricular electrodes
2.6
8.0
58
232
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.8
8.0
141
828
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.4
8.0
65
279
U14
ICPC
Kidney symptom/complaint
4.4
8.0
27
62
S22.3
ICD-10 Finland
Fracture of rib
2.3
8.0
71
320
-1
NOMESCO Finland
NA
1.5
7.9
303
2188
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
2.9
7.9
46
162
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.4
7.9
67
293
R03AC12
ATC
salmeterol; inhalant
2.6
7.9
56
224
I82.9
ICD-10 Finland
Embolism and thrombosis of unspecified vein
4.1
7.9
29
72
I80.1
ICD-10 Finland
Phlebitis and thrombophlebitis of femoral vein
4.6
7.9
26
58
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.8
7.9
130
749
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
7.8
7.9
17
22
RS121
NOMESCO Finland
NA
7.8
7.9
17
22
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
7.9
340
2524
F10.25
ICD-10 Finland
Alcohol dependence continuous use
6.1
7.9
20
33
4273A
ICD-9 Finland
Cardiac dysrhythmias, Atrial fibrillation and flutter
3.1
7.9
40
130
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
7.8
180
1146
SPAT1252
SPAT
Overall medication plan or its review
2.1
7.8
86
422
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
2.2
7.8
77
362
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.6
7.8
232
1580
K90
ICPC
Stroke/cerebrovascular accident
3.2
7.8
39
125
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
2.1
7.8
82
398
S29
ICPC
Skin symptom/complaint other
1.7
7.8
181
1155
D01
ICPC
Abdominal pain/cramps general
2.0
7.8
101
533
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
3.6
7.8
33
93
Z93.3
ICD-10 Finland
Colostomy status
9.5
7.8
15
16
R63.4
ICD-10 Finland
Abnormal weight loss
3.7
7.8
32
88
I33.0
ICD-10 Finland
Acute and subacute infective endocarditis
15.1
7.7
12
8
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.2
7.7
76
357
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
45.3
7.7
9
*
D73.5
ICD-10 Finland
Infarction of spleen
45.3
7.7
9
*
K25.0
ICD-10 Finland
Gastric ulcer, Acute with haemorrhage
4.6
7.7
25
55
P15
ICPC
Chronic alcohol abuse
4.1
7.7
28
69
XA402
NOMESCO Finland
ENMG
3.8
7.7
31
84
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
4.8
7.6
24
51
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
1.9
7.6
120
678
PC1CC
NOMESCO Finland
Very extensive angiography of aorta and abdominal arteries
18.5
7.6
11
6
RJ420
NOMESCO Finland
NA
18.5
7.6
11
6
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
5.0
7.6
23
47
K59.09
ICD-10 Finland
Constipation, unspecified
2.3
7.6
66
294
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
8.1
7.6
16
20
N06AA09
ATC
amitriptyline; systemic
2.0
7.6
101
536
F05.9
ICD-10 Finland
Delirium, unspecified
4.1
7.6
28
70
RJ410
NOMESCO Finland
NA
11.9
7.6
13
11
A10AE05
ATC
insulin detemir; parenteral
2.3
7.6
65
287
Y88.1
ICD-10 Finland
Sequelae of misadventures to patients during surgical and medical procedures
5.8
7.5
20
35
N17.8
ICD-10 Finland
Other acute renal failure
5.8
7.5
20
35
E66.8
ICD-10 Finland
Other obesity
2.8
7.5
46
169
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
3.0
7.5
43
149
H11.3
ICD-10 Finland
Conjunctival haemorrhage
2.5
7.5
55
222
M03BC01
ATC
orphenadrine (citrate); systemic
1.6
7.5
199
1317
AN2
HP
Balloon angioplasty, including several vessels
2.7
7.5
48
180
I35.2
ICD-10 Finland
Aortic (valve) stenosis with insufficiency
2.7
7.5
48
180
TFB00
NOMESCO Finland
Cathetrisation of pulmonal artery
3.8
7.5
30
81
K08.3
ICD-10 Finland
Retained dental root
2.1
7.5
79
384
A10AE04
ATC
insulin glargine; parenteral
1.9
7.5
104
564
TQW80
NOMESCO Finland
Local dermatologic skincare
3.5
7.4
33
97
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.5
7.4
33
97
S80.0
ICD-10 Finland
Contusion of knee
2.4
7.4
62
271
D68.4
ICD-10 Finland
Acquired coagulation factor deficiency
80.5
7.4
8
*
M10.0
ICD-10 Finland
Idiopathic gout
2.9
7.4
43
152
XF402
NOMESCO Finland
ECG with work load test
1.8
7.4
122
701
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.1
7.4
81
400
D68.8
ICD-10 Finland
Other specified coagulation defects
6.0
7.4
19
32
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
2.0
7.4
98
523
J45.1
ICD-10 Finland
Nonallergic asthma
2.2
7.4
76
364
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.6
7.4
229
1577
I71.4
ICD-10 Finland
Abdominal aortic aneurysm, without mention of rupture
3.1
7.4
38
125
WX320
NOMESCO Finland
Spinalanesthesy
1.6
7.4
237
1644
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
2.1
7.3
83
416
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.5
7.3
262
1860
RJ411
NOMESCO Finland
NA
8.4
7.3
15
18
DKW30
NOMESCO Finland
Cauterisation of artery of internal nose
8.4
7.3
15
18
F10.24
ICD-10 Finland
Alcohol depence active use
8.4
7.3
15
18
Z00.8
ICD-10 Finland
Other general examinations
2.2
7.3
74
354
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.6
7.3
200
1334
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.4
7.3
60
258
A40.8
ICD-10 Finland
Other streptococcal sepsis
6.9
7.3
17
25
QDA10
NOMESCO Finland
Incision of skin of lower limb
9.4
7.3
14
15
XCK10
NOMESCO Finland
Photography of fundus of eye
1.8
7.3
123
715
M54.6
ICD-10 Finland
Pain in thoracic spine
2.4
7.3
57
240
I48.1
ICD-10 Finland
Persistent atrial fibrillation
2.9
7.3
42
148
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.8
7.3
116
662
FN1AT
NOMESCO Finland
Endovascular dilatation of coronary arteries (PTCA)
2.2
7.2
71
335
C02AC05
ATC
moxonidine; oral
2.4
7.2
57
241
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
5.5
7.2
20
37
D63.8
ICD-10 Finland
Anaemia in other chronic diseases classified elsewhere
15.8
7.2
11
7
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.3
7.2
65
293
S70.1
ICD-10 Finland
Contusion of thigh
4.7
7.2
23
50
I80.0
ICD-10 Finland
Phlebitis and thrombophlebitis of superficial vessels of lower extremities
2.8
7.2
43
156
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
2.3
7.2
63
282
UJF92
NOMESCO Finland
Capsular endoscopy
4.0
7.2
27
69
K07
ICPC
Swollen ankles/oedema
2.5
7.2
56
234
103
Kela drug reimbursment
Diabetes, insulin-treated
1.5
7.2
304
2239
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
20.1
7.1
10
5
AN4
HP
Balloon angioplasty and drug eluding stent
2.7
7.1
47
181
M54.4
ICD-10 Finland
Lumbago with sciatica
1.7
7.1
140
852
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.7
7.1
162
1027
Z01.2
ICD-10 Finland
Dental examination
1.4
7.1
360
2748
K94
ICPC
Phlebitis/thrombophlebitis
4.6
7.1
23
51
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
3.8
7.1
28
75
K93
ICPC
Pulmonary embolism
6.1
7.1
18
30
R06.2
ICD-10 Finland
Wheezing
2.6
7.1
49
192
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.1
7.1
74
358
N04BC05
ATC
pramipexole; oral
2.0
7.1
83
422
A41.1
ICD-10 Finland
Sepsis due to other specified staphylococcus
10.1
7.0
13
13
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.4
7.0
433
3432
K70.3
ICD-10 Finland
Alcoholic cirrhosis of liver
4.7
7.0
22
47
SPAT1100
SPAT
Long-term monitoring of blood pressure
2.0
7.0
85
440
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
3.2
7.0
34
108
201
Kela drug reimbursment
Chronic cardiac insufficiency
2.1
7.0
73
353
S04
ICPC
Lump/swelling localized
1.9
6.9
94
503
C01BC04
ATC
flecainide; systemic
2.6
6.9
46
178
SPAT1131
SPAT
Colonoscopy
2.8
6.9
42
154
K59.1
ICD-10 Finland
Functional diarrhoea
2.4
6.9
58
253
L03
ICPC
Low back symptom/complaint
1.6
6.9
217
1492
I71.2
ICD-10 Finland
Thoracic aortic aneurysm, without mention of rupture
2.9
6.9
40
141
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
5.9
6.9
18
31
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.0
6.9
90
476
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.3
6.9
63
286
A02BC03
ATC
lansoprazole; oral
1.5
6.9
296
2185
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
7.6
6.9
15
20
E86
ICD-10 Finland
Volume depletion
3.6
6.9
29
82
N03AG01
ATC
valproic acid; systemic, rectal
2.7
6.9
45
172
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.7
6.9
44
164
K25.9
ICD-10 Finland
Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation
3.7
6.9
28
77
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.2
6.9
34
109
NHQ40
NOMESCO Finland
Amputation of toe
3.8
6.9
27
72
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
2.3
6.9
63
288
C07AA07
ATC
sotalol; systemic
2.3
6.9
60
267
GD1LA
NOMESCO Finland
GD
4.4
6.9
23
53
N39.9
ICD-10 Finland
Disorder of urinary system, unspecified
4.8
6.9
21
44
R4190
NOMESCO Finland
Nutritional therapy
3.0
6.8
36
121
W00
ICD-10 Finland
Fall on same level involving ice and snow
1.8
6.8
105
592
AP3
HP
Catheterization of the right and left side of the heart
11.0
6.8
12
11
N06AB06
ATC
sertraline; oral
2.0
6.8
87
458
AS2
HP
Ventricular pacemaker insertion VVI (R)
6.1
6.8
17
28
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.2
6.8
33
105
I80.8
ICD-10 Finland
Phlebitis and thrombophlebitis of other sites
5.7
6.8
18
32
M79.1
ICD-10 Finland
Myalgia
1.8
6.8
110
632
M03BX02
ATC
tizanidine; oral
1.4
6.8
545
4517
4019X
ICD-9 Finland
Essential hypertension, Unspecified
2.6
6.8
47
185
P29
ICPC
Psychological sympt/compl other
2.8
6.7
41
151
A10BH05
ATC
linagliptin; oral
2.3
6.7
60
271
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
6.7
437
3488
XG466
NOMESCO Finland
Sleep oxymetry
2.9
6.7
39
138
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.8
6.7
40
145
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
6.7
93
505
PDQ05
NOMESCO Finland
Insertion of endovascular graft into infrarenal abdominal aorta
7.2
6.7
15
21
S20.2
ICD-10 Finland
Contusion of thorax
2.5
6.7
51
213
NB6AA
NOMESCO Finland
Humerus X-ray examination
3.6
6.7
28
79
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.2
6.7
64
297
JCA22
NOMESCO Finland
Endoscopic ligature of oesophageal varices
22.6
6.7
9
*
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
6.7
484
3938
D07BC01
ATC
betamethasone and antiseptics; topical
1.8
6.6
119
704
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
3.6
6.6
28
80
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
2.3
6.6
58
258
3A064
NOMESCO Finland
NA
12.3
6.6
11
9
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.9
6.6
86
458
TEW99
NOMESCO Finland
Other minor procedure in surgery of teeth, jaws, mouth and pharynx
2.6
6.6
46
182
R05FB02
ATC
cough suppressants and expectorants
1.4
6.6
384
3005
I34.1
ICD-10 Finland
Mitral (valve) prolapse
3.0
6.6
35
119
C08DA01
ATC
verapamil; systemic
2.4
6.6
55
239
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
2.9
6.5
38
135
K84
ICPC
Heart disease other
2.9
6.5
38
135
SPAT1251
SPAT
Organisation of medication
2.6
6.5
46
183
J01XX08
ATC
linezolid; systemic
10.1
6.5
12
12
L03AA02
ATC
filgrastim; parenteral
4.2
6.5
23
56
TQW40
NOMESCO Finland
Remowal of suture of skin
2.0
6.5
75
380
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
2.6
6.5
46
184
N05AX12
ATC
aripiprazole; systemic
4.0
6.5
24
61
T81.9
ICD-10 Finland
Unspecified complication of procedure
4.0
6.5
24
61
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
3.7
6.5
26
71
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
3.8
6.5
25
66
I42.0
ICD-10 Finland
Dilated cardiomyopathy
2.9
6.4
37
130
GBB00
NOMESCO Finland
Tracheostomy
4.3
6.4
22
52
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
3.0
6.4
34
115
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
70.2
6.4
7
*
PH7FT
NOMESCO Finland
Inmplantation of filter to inferior vena cava with radiological guidance
70.2
6.4
7
*
R59.9
ICD-10 Finland
Enlarged lymph nodes, unspecified
70.2
6.4
7
*
PAW37
NOMESCO Finland
Biopsy of temporal artery
7.4
6.4
14
19
ZX121
NOMESCO Finland
Central venous catheter
14.4
6.4
10
7
XX1XW
NOMESCO Finland
Extensive written report from radiologist
3.7
6.4
26
72
C10AA03
ATC
pravastatin; oral
1.9
6.4
88
476
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
3.9
6.4
24
62
M16.1
ICD-10 Finland
Other primary coxarthrosis
1.7
6.4
138
863
TGC00
NOMESCO Finland
Bronchial lavation
3.1
6.4
33
110
SPAT1285
SPAT
Provision of consultation response
2.2
6.4
62
291
WYA10
NOMESCO Finland
First aid or other corresponding healthcare contact
2.1
6.4
71
352
F33.4
ICD-10 Finland
Recurrent depressive disorder, currently in remission
4.9
6.4
19
39
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.6
6.3
42
163
B82
ICPC
Anaemia other/unspecified
3.1
6.3
32
105
A10BH01
ATC
sitagliptin; oral
1.8
6.3
113
668
RF120
NOMESCO Finland
NA
5.2
6.3
18
35
S89.9
ICD-10 Finland
Unspecified injury of lower leg
3.2
6.3
30
94
J09
ICD-10 Finland
Influenza due to identified zoonotic or pandemic influenza virus
3.5
6.3
27
78
SXC03
NOMESCO Finland
Other oral or dental procedure
6.0
6.3
16
27
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
6.0
6.3
16
27
S30.1
ICD-10 Finland
Contusion of abdominal wall
5.5
6.3
17
31
D70.82
ICD-10 Finland
Drug-induced neutropenia
5.5
6.3
17
31
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.8
6.3
106
616
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
11.1
6.3
11
10
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.7
6.3
25
68
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
3.9
6.3
24
63
KA3EB
NOMESCO Finland
Antegrade pyelography
9.3
6.3
12
13
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
9.3
6.3
12
13
K04.7
ICD-10 Finland
Periapical abscess without sinus
2.3
6.3
52
228
RJ414
NOMESCO Finland
NA
18.1
6.3
9
5
I20.90
ICD-10 Finland
Angina pectoris, unspecified
2.4
6.3
51
221
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
2.9
6.3
36
127
KAS40
NOMESCO Finland
Excision of transplanted kidney
+∞
6.3
6
*
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
26.8
6.2
8
*
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
26.8
6.2
8
*
L08
ICPC
Shoulder symptom/complaint
1.6
6.2
180
1215
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.9
6.2
83
445
RF210
NOMESCO Finland
NA
2.9
6.2
34
118
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
2.4
6.2
50
213
PH2DE
NOMESCO Finland
Ultrasound examination of bloodflow in veins of lower extremity with Doppler method
3.3
6.2
29
90
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
6.2
112
666
WX725
NOMESCO Finland
Noninvasive ventilation
2.5
6.2
47
195
R51.81
ICD-10 Finland
Facial pain NOS
6.3
6.2
15
24
R10.0
ICD-10 Finland
Acute abdomen
3.0
6.2
33
113
NF1DA
NOMESCO Finland
X-ray of hips
3.0
6.2
33
113
M54.2
ICD-10 Finland
Cervicalgia
2.1
6.2
63
303
GD2SN
NOMESCO Finland
Lung ventilation SPECT
7.7
6.1
13
17
A01AB09
ATC
miconazole; local oral
1.8
6.1
92
516
WX290
NOMESCO Finland
Other blockade of nerve
1.4
6.1
353
2749
T14.0
ICD-10 Finland
Superficial injury of unspecified body region
4.7
6.1
19
41
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
3.7
6.1
24
65
C08CA03
ATC
isradipine; systemic
3.9
6.1
23
60
A10BH02
ATC
vildagliptin; oral
3.1
6.1
30
97
XCK00
NOMESCO Finland
Perimetry
2.0
6.1
76
399
KMAK
NOMESCO Finland
NA
1.4
6.1
460
3756
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.8
6.1
104
609
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
8.6
6.1
12
14
F34.1
ICD-10 Finland
Dysthymia
3.0
6.0
32
109
FPW96
NOMESCO Finland
Other operation for arhythmia or disturbance of impulse propagation
10.1
6.0
11
11
PD4AD
NOMESCO Finland
CT of lower extremity arteries
10.1
6.0
11
11
L13
ICPC
Hip symptom/complaint
1.6
6.0
156
1024
A05
ICPC
Feeling ill
2.4
6.0
49
211
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
2.8
6.0
36
132
S01.50
ICD-10 Finland
Open wound in oral cavity
5.2
6.0
17
33
A10BA02
ATC
metformin; oral
1.4
6.0
307
2338
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
244
359
8.04
163.05
5.8
2.7
u/ml
0.3
0.4
1.02
170
193
(3018677) aPTT in Platelet poor plasma by Coagulation assay
506
1528
4.64
154.73
4.5
1.9
s
31.9
29.9
7.77
489
1480
(3023368) Bacteria identified in Blood by Culture
683
2770
3.89
135.14
7.5
3.4
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
183
250
8.28
129.44
5.2
2.4
g/l
3.6
3.6
0.09
170
240
(3032080) INR in Blood by Coagulation assay
894
4457
3.83
126.83
23.5
9.1
inr
1.5
1.3
4.73
274
1172
(3012095) Magnesium [Moles/volume] in Serum or Plasma
459
1516
4.03
120.40
4.6
2.7
mmol/l
0.8
0.8
0.31
428
1407
(3022217) INR in Platelet poor plasma by Coagulation assay
450
1467
4.06
120.22
43.6
29.2
inr
1.8
1.5
2.50
52
181
(3022948) Iron [Moles/volume] in Serum or Plasma
457
1551
3.90
114.56
4.8
2.3
umol/l
10.6
12.9
9.24
419
1438
(3004789) Transferrin [Mass/volume] in Serum or Plasma
433
1432
3.94
112.44
4.9
2.3
g/l
2.2
2.3
2.42
403
1324
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
414
1335
4.00
111.36
5.2
2.4
%
19.5
22.7
4.70
361
1116
(3020779) Urea [Moles/volume] in Serum or Plasma
327
894
4.48
110.08
14.3
5.4
mmol/l
12.2
10.7
2.72
315
840
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
157
233
7.47
102.74
5.6
2.3
%
201.2
191.2
0.55
149
223
(3003458) Phosphate [Moles/volume] in Serum or Plasma
393
1306
3.80
100.05
12.7
4.8
mmol/l
1.1
1.0
6.71
368
1198
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
927
5217
3.35
98.41
9.3
5.2
umol/l
13.7
12.3
1.19
900
4912
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
486
1898
3.40
95.79
3.1
1.6
mg/l
2.5
1.5
2.09
388
1475
(3014111) Lactate [Moles/volume] in Serum or Plasma
298
842
4.23
95.04
10.5
6.8
mmol/l
1.5
1.4
0.48
287
810
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
924
5264
3.27
94.53
14.9
5.8
mmol/l
1.2
1.2
8.51
793
4402
(3042936) Bacteria identified in Isolate by Culture
397
1375
3.64
94.39
3.0
1.9
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
352
1129
3.84
93.83
4.1
3.4
u/l
285.8
242.8
3.37
330
1068
(3024561) Albumin [Mass/volume] in Serum or Plasma
837
4527
3.14
93.39
8.9
4.1
g/l
33.3
35.2
16.80
791
4157
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
603
2720
3.15
92.66
3.4
2.1
mg/l
3.7
3.1
4.29
532
2288
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
860
4775
3.11
90.58
13.5
5.2
mmol/l
1.2
1.2
8.31
801
4223
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
429
1603
3.43
90.06
2.3
1.6
—
—
—
0
0
(3000991) Gas panel - Venous blood
288
827
4.13
89.49
13.9
7.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
729
3741
3.00
87.70
5.0
2.9
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
630
2985
3.04
87.64
3.8
2.2
u/l
56.2
58.9
0.92
592
2716
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
151
254
6.55
87.53
4.7
2.5
%
88.3
89.2
0.17
146
241
(3013826) Glucose [Moles/volume] in Serum or Plasma
999
6107
3.28
87.45
9.3
4.0
mmol/l
6.9
6.8
0.30
955
5669
(3044640) Blood type and Crossmatch panel - Blood
668
3284
3.00
86.66
4.3
2.4
—
—
—
0
0
(3036489) Thrombin time
163
304
5.94
85.03
4.6
2.0
s
22.7
22.1
0.29
143
276
(3014576) Chloride [Moles/volume] in Serum or Plasma
364
1271
3.53
84.49
11.6
6.4
mmol/l
103.8
104.5
1.88
359
1243
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
345
1167
3.60
84.08
10.9
6.7
kpa
5.0
5.1
2.45
323
1107
(3027801) Oxygen [Partial pressure] in Arterial blood
345
1168
3.60
83.96
10.8
6.7
kpa
11.4
12.1
1.71
321
1109
(3022096) Basophils/100 leukocytes in Blood
804
4425
2.95
83.74
8.7
5.0
%
0.6
0.7
0.65
763
4064
(3013650) Neutrophils [#/volume] in Blood by Automated count
945
5700
3.07
82.60
12.4
7.4
e9/l
4.8
4.2
5.46
848
4874
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
246
666
4.27
82.39
2.0
1.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
818
4598
2.90
80.92
9.2
5.2
%
9.0
8.8
0.74
775
4239
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
612
2956
2.92
80.64
2.7
1.9
u/l
186.7
270.4
1.73
577
2747
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
665
3358
2.88
80.58
4.6
2.8
ng/l
3089.7
1683.3
5.32
599
2884
(3006504) Eosinophils/100 leukocytes in Blood
814
4573
2.89
80.45
8.9
5.0
%
2.8
2.9
1.16
771
4192
(3003396) Base excess in Arterial blood by calculation
337
1168
3.49
78.61
11.1
6.7
mmol/l
0.9
1.1
0.33
268
896
(3002030) Lymphocytes/100 leukocytes in Blood
826
4715
2.86
78.50
9.1
5.1
%
22.9
27.1
19.56
780
4328
(3001122) Ferritin [Mass/volume] in Serum or Plasma
757
4167
2.80
76.56
5.1
2.6
ug/l
180.0
130.9
2.70
703
3779
(3027945) Reticulocytes/100 erythrocytes in Blood
345
1232
3.40
76.55
3.2
2.3
%
1.9
1.7
1.84
300
1082
(3013115) Eosinophils [#/volume] in Blood
855
5014
2.84
76.35
8.9
5.1
e9/l
0.2
0.2
0.20
767
4311
(3006315) Basophils [#/volume] in Blood
835
4838
2.83
76.32
8.4
4.8
e9/l
0.0
0.0
0.62
738
4075
(3001604) Monocytes [#/volume] in Blood
833
4822
2.82
76.25
8.4
4.8
e9/l
0.6
0.6
2.18
737
4056
(3021447) Carbon dioxide [Partial pressure] in Venous blood
292
942
3.66
75.86
7.2
3.3
kpa
5.8
5.8
0.38
286
920
(3002582) Erythrocytes [#/volume] in Urine
630
3173
2.81
75.49
5.2
2.8
e6/l
72.0
89.2
0.25
536
2439
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
837
4873
2.81
75.49
6.5
3.9
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
327
1142
3.44
75.06
2.6
1.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
290
938
3.65
74.98
7.3
3.3
mmol/l
1.8
1.8
0.01
245
723
(3019198) Lymphocytes [#/volume] in Blood
846
4967
2.80
74.80
8.6
4.9
e9/l
1.7
1.9
3.37
759
4273
(3018010) Neutrophils/100 leukocytes in Blood
805
4642
2.75
73.17
8.9
4.9
%
61.5
57.9
11.76
763
4277
(3026782) Osmolality of Urine
468
2050
2.94
72.51
4.4
2.4
mosm/kgh2o
521.3
561.2
3.46
420
1725
(3033658) Prothrombin time (PT) actual/Normal
528
2507
2.79
69.77
9.6
3.5
%
77.4
86.3
8.53
517
2447
(3016502) Oxygen saturation in Arterial blood
301
1048
3.39
68.94
11.7
7.1
%
95.8
95.4
0.59
287
1005
(3023183) Ammonium ion [Moles/volume] in Plasma
106
158
7.18
68.62
2.9
2.4
umol/l
36.4
31.9
1.04
96
128
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
721
4033
2.64
68.10
6.5
3.3
ng/l
79.2
63.7
0.44
600
2925
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
303
1067
3.35
68.07
3.8
2.4
umol/l
11.9
9.9
0.54
265
932
(3030467) Casts [#/volume] in Urine by Automated count
577
2906
2.69
67.37
5.1
2.8
e6/l
0.7
0.5
0.49
475
2195
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
523
2511
2.74
67.13
4.0
2.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
676
3701
2.61
66.22
5.9
3.2
e6/l
76.6
95.2
0.38
561
2622
(3018418) pH of Serum or Plasma
592
3049
2.64
65.67
8.9
3.4
ph
7.4
7.4
0.09
132
539
(3000850) Epithelial cells [#/volume] in Urine
478
2213
2.77
65.63
4.0
2.3
e6/l
5.2
4.9
0.27
435
1941
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
187
488
4.27
65.11
2.0
1.5
g/l
1.3
1.5
2.54
151
413
(42870588) Differential panel, method unspecified - Blood
628
3345
2.60
64.77
8.5
4.9
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
300
1085
3.25
64.21
2.4
1.6
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
247
794
3.57
63.80
5.7
2.7
kpa
5.2
4.6
3.05
238
774
(3026008) Bacteria identified in Urine by Culture
614
3257
2.59
63.58
4.6
2.9
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
182
474
4.27
63.48
8.8
3.7
mmol/l
24.0
23.9
0.27
173
430
(3002173) Hemoglobin [Mass/volume] in Arterial blood
277
966
3.33
62.85
12.3
7.4
g/l
114.6
120.5
4.09
269
920
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
297
1088
3.20
62.05
2.3
1.6
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
191
528
4.04
61.38
13.6
9.2
mmol/l
23.9
24.3
0.68
170
494
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
81
102
8.37
60.59
6.2
5.3
mg/l
12.2
11.8
0.26
71
96
(36304419) Bacteria [Presence] in Urine
547
2815
2.56
59.48
5.0
2.7
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
1018
6998
2.71
58.95
7.1
4.1
e6/l
96.5
2146.8
2.12
21
117
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
430
1978
2.70
58.78
6.5
3.6
ng/l
488.5
479.7
0.02
375
1668
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1114
8067
2.94
57.25
13.1
6.3
u/l
87.8
79.3
4.21
1072
7468
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
189
545
3.86
57.07
1.9
1.4
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
564
2994
2.49
56.81
4.5
2.8
u/l
37.2
33.5
1.01
532
2848
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
149
367
4.43
55.69
2.2
1.6
ug/l
3.6
1.7
0.36
137
311
(3023520) Reticulocytes [#/volume] in Blood
254
909
3.20
54.70
2.9
2.2
e9/l
71.2
67.7
0.86
198
689
(3020630) Protein [Mass/volume] in Serum or Plasma
232
810
3.24
51.91
2.2
2.5
g/l
64.7
66.5
2.40
215
727
(40758558) Short blood count panel - Blood
478
2457
2.44
50.49
10.0
5.8
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
499
2619
2.41
50.26
3.9
2.6
umol/l
4073.4
8201.1
1.18
444
2231
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
362
1662
2.59
48.43
4.1
2.6
e6/l
3.6
2.3
1.17
219
913
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
76
116
6.87
47.96
7.7
3.9
iu/ml
154.3
1982.9
0.71
15
14
(3042733) HLA Ab [Presence] in Serum
33
13
25.98
47.21
5.5
4.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
229
854
3.01
45.42
2.5
1.5
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
229
855
3.01
45.32
3.6
2.2
u/l
120.0
45.8
0.41
208
719
(3037467) Urinalysis macro (dipstick) panel - Urine
997
7205
2.37
44.89
6.8
3.9
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
110
254
4.62
44.42
2.1
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
92
186
5.23
43.47
1.7
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
92
186
5.23
43.47
1.7
1.3
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
36
22
16.77
42.79
1.3
1.0
%
87.8
95.8
0.36
25
15
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
36
22
16.77
42.79
1.2
1.0
%
87.8
94.9
0.60
25
15
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
172
561
3.36
42.65
14.6
9.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
234
916
2.87
42.33
2.8
2.1
g/l
0.2
0.2
1.01
209
858
(3015377) Calcium [Moles/volume] in Serum or Plasma
598
3600
2.16
41.48
4.1
3.1
mmol/l
2.3
2.4
5.39
520
3035
(3009343) pH of Capillary blood
188
658
3.15
41.45
4.6
3.6
ph
7.4
7.4
1.74
33
61
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
190
670
3.13
41.36
4.6
3.6
kpa
5.1
5.2
0.01
171
617
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
184
638
3.17
41.21
4.5
3.6
mmol/l
2.4
1.7
1.08
127
459
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
70
116
6.30
40.78
1.8
1.3
u/ml
156.4
114.8
0.42
14
22
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
64
97
6.87
40.61
1.5
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
79
148
5.60
40.57
1.6
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
75
134
5.86
40.49
1.8
1.3
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
360
1783
2.38
39.92
3.9
2.4
e6/l
1.0
1.2
0.73
218
1032
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
242
994
2.74
39.80
3.9
2.9
ng/l
367.9
231.1
3.18
219
915
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
80
155
5.42
39.60
1.5
1.3
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
260
1111
2.65
39.53
5.6
3.1
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
473
2647
2.19
38.99
1.8
1.5
nmol/l
19.8
20.7
0.55
415
2215
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
649
4103
2.09
38.87
2.8
2.1
nmol/l
76.5
78.3
0.89
594
3555
(3028626) Oxygen [Partial pressure] in Capillary blood
96
222
4.57
38.64
4.3
3.1
kpa
8.2
8.4
0.34
88
207
(3005719) IgG [Mass/volume] in Serum or Plasma
168
574
3.19
38.47
2.9
2.5
g/l
10.5
10.8
0.31
156
511
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
232
955
2.72
37.88
2.8
2.1
ug/l
9.2
7.3
0.63
205
816
(3019309) Folate [Moles/volume] in Red Blood Cells
404
2150
2.24
37.48
2.1
1.7
nmol/l
1224.0
1151.6
0.74
315
1590
(46235355) HIV 1 and 2 tests - Meaningful Use set
274
1235
2.52
37.12
2.4
1.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
689
4508
2.05
37.01
18.0
8.0
e9/l
0.0
0.0
1.05
578
3632
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
697
4606
2.03
36.13
2.5
2.0
pmol/l
93.1
93.6
0.09
396
2337
(3015235) Bicarbonate [Moles/volume] in Capillary blood
95
230
4.36
36.06
3.7
2.9
mmol/l
24.5
24.9
0.27
84
195
(3037522) Nuclear Ab [Titer] in Serum
245
1061
2.59
36.01
1.3
1.3
titre
480.7
480.0
0.00
57
213
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
112
309
3.86
35.62
2.5
3.5
ratio
1.9
1.4
—
10
22
(3036481) Cortisol [Moles/volume] in Serum or Plasma
180
669
2.94
35.51
2.2
2.0
nmol/l
391.9
384.5
0.18
172
596
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
54
79
7.07
35.37
1.6
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
1006
7644
2.15
34.91
5.8
3.6
mm/h
16.6
12.9
8.71
929
6936
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
196
777
2.77
34.24
8.3
3.5
ng/l
150.8
90.3
6.05
174
654
(3027456) Digoxin [Moles/volume] in Serum or Plasma
104
280
3.93
34.22
3.6
2.9
nmol/l
0.9
0.9
0.44
87
218
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
112
318
3.74
34.16
2.5
3.6
mg/l
43.5
63.9
0.55
91
273
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1245
10403
2.93
34.11
40.0
12.4
mg/l
26.8
26.8
0.02
1159
8078
(3034860) Kappa light chains.free [Mass/volume] in Serum
112
319
3.73
34.00
2.5
3.5
mg/l
103.8
80.3
0.15
90
272
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
47
62
7.81
33.70
1.6
1.5
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
101
271
3.94
33.38
1.4
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
242
1079
2.51
33.29
2.4
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
75
160
4.90
33.25
2.9
2.9
—
—
—
0
0
(3019060) Gas panel - Arterial blood
176
669
2.87
33.24
6.2
4.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
175
668
2.85
32.78
2.1
2.5
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
165
613
2.92
32.47
5.0
2.9
g/l
119.6
128.8
5.23
160
601
(40767503) Oxygen content in Capillary blood by calculation
78
177
4.61
32.10
2.8
2.1
%
15.2
16.5
1.40
42
87
(1616796) Gas panel - Central venous blood
76
172
4.62
31.37
5.7
3.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
103
297
3.67
30.67
6.1
3.2
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
97
270
3.79
30.41
1.6
1.5
titre
157.1
190.0
—
7
12
(3017181) Myelocytes/100 leukocytes in Blood
188
783
2.62
29.62
5.1
3.4
%
1.2
0.9
0.65
73
199
(40760892) CBC W Ordered Manual Differential panel - Blood
353
1940
2.10
29.14
5.7
3.7
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
61
124
5.10
28.59
1.5
1.1
u/ml
288.7
300.8
0.08
41
64
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
75
181
4.32
28.55
1.6
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
180
749
2.61
28.36
5.0
3.5
%
0.2
0.1
0.78
72
182
(3028026) IgM [Mass/volume] in Serum or Plasma
130
458
3.03
28.03
1.6
1.7
g/l
1.1
1.4
0.94
120
413
(3007164) IgA [Mass/volume] in Serum or Plasma
305
1609
2.15
27.88
1.5
1.3
g/l
2.7
2.6
0.41
190
903
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
162
646
2.71
27.76
2.0
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
261
1297
2.25
27.68
1.3
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
172
708
2.63
27.67
5.1
3.5
%
0.1
0.7
0.61
60
156
(3024928) Oxygen saturation in Venous blood
77
195
4.12
27.51
4.4
3.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
88
247
3.74
27.24
1.4
1.4
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
61
130
4.86
27.06
1.5
1.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
80
211
3.96
27.04
1.3
1.2
—
13.2
—
0
5
(3035350) Ketones [Presence] in Urine by Test strip
703
4995
1.83
26.20
5.5
3.3
estimate
0.0
0.0
0.00
167
892
(3012501) Base excess in Blood by calculation
72
180
4.16
26.16
6.5
3.4
mmol/l
2.6
2.6
0.00
55
120
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
54
107
5.21
26.04
1.4
1.2
u/ml
7.4
5.9
0.17
29
45
(40760888) Immunoglobulin light chains.free panel - Serum
82
228
3.76
25.72
2.4
3.5
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
168
708
2.56
25.70
4.8
3.2
%
0.6
0.5
0.39
52
138
(3008152) Bicarbonate [Moles/volume] in Arterial blood
157
644
2.62
25.37
9.8
6.0
mmol/l
24.7
24.5
0.27
150
592
(3024891) Influenza virus A+B Ag [Presence] in Specimen
78
212
3.84
25.28
1.4
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
353
2040
1.98
24.84
3.7
2.8
mmol/l
2.5
2.5
0.10
312
1764
(3009261) Glucose [Presence] in Urine by Test strip
706
5076
1.80
24.80
5.5
3.4
estimate
0.0
0.0
0.50
160
879
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
21
13
16.39
24.59
22.0
8.4
mmol/l
4.3
6.2
0.98
21
13
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
815
6126
1.80
24.52
4.8
2.8
u/l
74.4
48.4
7.08
759
5590
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
53
109
5.02
24.51
1.4
1.2
u/ml
4.2
4.8
0.07
22
34
(3021601) Nitrite [Presence] in Urine by Test strip
695
5003
1.78
24.05
7.5
4.6
estimate
0.0
0.0
0.00
165
888
(3022493) Free Hemoglobin [Mass/volume] in Plasma
30
35
8.74
23.70
2.7
1.4
mg/l
63.6
68.4
0.13
24
30
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
45
83
5.57
23.47
1.4
1.3
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
731
5377
1.76
23.14
3.0
2.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
73
203
3.74
22.89
1.6
1.2
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
116
432
2.84
22.56
5.4
4.2
%
1.8
1.6
1.00
108
400
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
52
113
4.74
22.55
1.5
1.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1254
11001
2.47
22.34
46.0
15.3
mmol/l
139.0
139.7
14.74
1230
10657
(4306422)
50
106
4.86
22.32
1.3
1.2
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1255
11027
2.46
22.04
46.6
15.5
mmol/l
4.0
4.0
1.93
1228
10658
(3021879) Hepatitis B virus core Ab [Presence] in Serum
134
545
2.61
21.96
1.6
1.4
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
69
194
3.69
21.30
2.3
1.3
g/l
0.2
0.2
0.58
63
185
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
96
334
3.01
21.09
2.5
2.5
—
—
—
0
0
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
71
205
3.60
21.08
2.2
1.3
g/l
1.2
1.2
0.48
66
194
(3007930) Methemoglobin/Hemoglobin.total in Blood
112
426
2.77
20.92
5.5
4.3
%
0.9
0.9
0.02
103
396
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
47
100
4.83
20.90
1.4
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
80
251
3.32
20.89
5.5
3.3
mg/l
2.3
1.6
4.63
74
221
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
82
264
3.24
20.54
1.6
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
103
382
2.83
20.16
2.4
2.7
g/l
3.7
3.9
0.57
79
271
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
103
382
2.83
20.16
2.4
2.7
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
103
382
2.83
20.16
2.4
2.7
g/l
7.2
7.6
1.41
81
282
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
85
283
3.13
20.14
2.6
2.7
g/l
0.0
0.0
1.17
79
254
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
31
46
6.87
20.01
1.4
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
175
841
2.24
19.76
6.9
2.8
mmol/l
1.2
1.2
1.89
160
708
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
47
105
4.60
19.72
1.2
1.1
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
18
13
14.02
19.37
1.1
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
34
58
5.98
19.22
1.1
1.2
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
35
62
5.77
19.04
2.3
2.5
—
—
—
0
0
(3002256) Pathology report gross observation
241
1329
1.98
18.90
1.4
1.3
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
95
350
2.84
18.82
2.5
2.8
g/l
3.3
3.2
0.26
80
275
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
68
208
3.39
18.49
1.4
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
120
505
2.51
18.28
5.1
3.7
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
55
148
3.83
18.09
3.8
3.3
%
1.4
0.8
0.54
46
109
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
41
88
4.77
18.06
1.4
1.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
42
92
4.68
18.05
4.7
2.7
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
46
109
4.33
17.94
2.0
1.4
%
89.4
90.0
0.22
46
109
(3013512) EKG study
467
3195
1.70
17.90
6.4
3.9
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
90
331
2.84
17.89
2.5
2.8
g/l
0.8
1.2
0.42
81
276
(3000475) Leukocytes [#/volume] in Synovial fluid
72
234
3.19
17.77
1.7
1.7
e6/l
18330.9
17348.3
0.04
54
170
(3025941) Bacteria identified in Stool by Culture
109
444
2.58
17.76
1.4
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
39
82
4.86
17.60
1.4
1.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
95
363
2.74
17.57
2.4
2.7
g/l
10.0
10.3
0.29
87
303
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
79
274
3.00
17.45
2.6
2.7
g/l
0.0
0.0
0.00
74
247
(3006184) Hemoglobin [Mass/volume] in Capillary blood
66
208
3.28
17.13
2.5
2.0
g/l
121.2
131.2
1.99
51
137
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
210
1140
1.99
17.12
4.1
4.0
ug/l
8.8
18.0
0.94
170
948
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
17
14
12.28
16.93
1.1
1.1
—
—
—
0
0
(44790047)
37
77
4.91
16.90
1.8
1.4
—
—
—
0
0
(44806118)
37
77
4.91
16.90
1.8
1.4
—
—
—
0
0
(44790048)
37
77
4.91
16.90
1.8
1.4
—
—
—
0
0
(44790049)
37
77
4.91
16.90
1.8
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
84
308
2.84
16.80
2.5
2.6
g/l
36.9
37.4
0.32
76
258
(3003181) Sodium [Moles/volume] in Urine
55
156
3.63
16.79
1.4
1.3
mmol/l
60.4
60.1
0.02
38
123
(4268621)
37
78
4.85
16.65
2.4
2.2
—
—
—
0
0
(3044889) 12 lead EKG panel
910
7456
1.64
16.47
5.7
3.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
408
2746
1.69
16.35
5.8
3.6
estimate
0.0
0.0
0.10
150
861
(40768446) Kidney Pathology biopsy report
19
20
9.62
16.13
2.3
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
200
1092
1.97
15.98
1.9
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
559
4095
1.61
15.92
2.7
2.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
23
32
7.29
15.70
1.3
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1123
9775
1.78
15.70
33.7
12.4
ml/min/173m2
71.4
75.7
6.43
1010
7872
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1095
9481
1.74
15.37
5.5
4.4
mu/l
2.1
2.0
1.39
1001
8451
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
528
3840
1.61
15.35
6.0
3.6
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
55
166
3.41
15.30
1.3
1.6
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
67
229
3.02
15.20
1.2
1.2
titre
88.0
100.7
—
5
14
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
34
73
4.75
14.98
1.7
1.4
%
20.9
24.1
0.24
25
45
(3020891) Body temperature
93
383
2.53
14.81
7.9
3.8
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
19
23
8.36
14.52
1.3
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
19
23
8.36
14.52
1.3
1.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
66
230
2.96
14.48
1.7
1.3
—
—
—
0
0
(3024471) HLA-A [Type]
15
13
11.65
14.44
1.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
15
13
11.65
14.44
1.0
1.2
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
37
88
4.29
14.39
1.1
1.3
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
925
7735
1.59
14.22
4.5
3.6
pmol/l
15.0
15.0
0.09
838
6834
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
52
159
3.36
14.19
3.3
3.0
%
59.7
58.0
0.30
52
159
(3017569) Oxygen content in Arterial blood
25
43
5.90
14.02
2.2
1.7
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
20
27
7.50
14.00
2.8
2.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
28
54
5.27
13.94
5.6
3.1
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
382
2621
1.63
13.82
5.6
3.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1233
11160
1.95
13.69
18.2
9.4
u/l
25.5
25.3
0.12
1198
10611
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
349
2348
1.65
13.62
1.9
1.7
pmol/l
416.5
19729730.1
1.51
275
1921
(40761511) CBC panel - Blood by Automated count
1212
10921
1.87
13.47
37.3
12.4
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
45
130
3.54
13.40
2.7
2.7
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
43
121
3.64
13.31
2.1
2.4
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
47
141
3.42
13.22
1.4
1.4
e6/l
42836.6
63923.9
0.31
24
84
(3011397) Hemoglobin [Presence] in Urine by Test strip
352
2389
1.63
13.22
4.6
3.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
101
456
2.31
13.15
5.2
3.8
mmol/l
25.0
24.8
0.23
93
419
(3048689) Calprotectin [Mass/mass] in Stool
175
984
1.89
12.70
2.9
2.3
ug/g
308.6
139.4
1.74
131
758
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
17
7
24.55
12.47
1.1
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
26
52
5.08
12.44
1.3
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
26
52
5.08
12.44
1.3
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
292
1918
1.66
12.38
1.4
1.3
u/ml
1.9
1.6
0.19
80
494
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
39
108
3.69
12.37
1.5
1.6
%
65.3
67.5
0.14
28
69
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
22
38
5.87
12.28
1.3
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
18
25
7.28
12.28
1.2
1.1
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
48
153
3.21
12.28
1.1
1.2
u/ml
3.0
2.5
—
5
12
(3009542) Hematocrit [Volume Fraction] of Blood
1067
9358
1.61
12.21
42.9
14.5
%
36.5
39.1
12.14
682
6163
(3023199) Leukocytes [#/volume] in Pleural fluid
48
154
3.19
12.15
1.5
1.4
e6/l
954.8
1623.0
1.61
28
110
(3022145) Colonoscopy Study observation
186
1084
1.83
12.03
1.3
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
51
171
3.06
12.00
1.5
1.4
g/l
29.9
32.4
0.74
44
155
(3009508) Creatinine [Moles/volume] in Urine
479
3558
1.53
11.96
3.6
3.1
mmol/l
6.9
7.3
1.29
402
2919
(44816559) Phosphatidylethanol [Mass/volume] in Blood
43
131
3.36
11.83
1.4
1.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
987
8538
1.54
11.64
49.9
15.9
%
14.6
13.7
39.97
975
8295
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
149
819
1.92
11.56
4.1
2.8
ml/min/173m2
55.9
62.9
1.31
82
325
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
21
37
5.75
11.49
1.2
1.1
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1266
11682
1.97
11.47
56.5
19.2
e9/l
237.9
243.9
1.87
1245
11282
(3008757) Leukocyte morphology finding [Identifier] in Blood
39
114
3.49
11.44
4.5
3.4
—
—
—
0
0
(3024731) MCV [Entitic volume]
1266
11685
1.96
11.42
56.3
19.1
fl
91.7
91.3
2.01
1251
11432
(3035941) MCH [Entitic mass]
1266
11685
1.96
11.42
56.3
19.1
pg
30.1
30.4
3.26
1251
11431
(3026361) Erythrocytes [#/volume] in Blood
1266
11686
1.96
11.40
56.5
19.1
e12/l
4.2
4.5
44.16
1235
11243
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
87
392
2.30
11.40
3.5
3.0
u/ml
212.1
3640.9
0.72
73
329
(3010813) Leukocytes [#/volume] in Blood
1266
11689
1.96
11.34
56.6
19.2
e9/l
7.6
6.8
5.37
1238
11237
(3000963) Hemoglobin [Mass/volume] in Blood
1266
11689
1.96
11.34
57.0
19.3
g/l
125.0
134.6
71.95
1250
11437
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
23
45
5.18
11.28
3.0
2.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
222
1389
1.71
11.21
1.3
1.2
u/ml
28.5
15.3
0.78
79
509
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
92
428
2.23
11.18
2.1
1.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
42
131
3.28
11.15
1.5
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
387
2779
1.54
11.14
1.4
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
15
19
7.97
11.02
1.1
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
25
54
4.70
10.97
2.2
1.6
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
482
3638
1.50
10.94
4.5
3.9
mg/mmol
23.0
8.2
3.10
349
2245
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
86
394
2.26
10.84
1.9
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
61
239
2.62
10.80
1.7
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
43
140
3.14
10.65
1.9
1.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
46
156
3.02
10.64
1.4
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
26
60
4.40
10.54
1.5
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
46
157
3.00
10.53
6.3
2.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
42
137
3.13
10.38
1.5
1.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
73
318
2.37
10.34
6.8
5.4
mmol/l
1.3
1.3
0.01
65
275
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
29
74
3.98
10.33
1.3
1.2
titre
56.0
173.5
—
5
17
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
30
79
3.86
10.24
1.3
1.2
nmol/l
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
224
1442
1.66
10.11
1.3
1.2
iu/ml
36.7
38.1
0.05
77
455
(3005322) IgE [Units/volume] in Serum or Plasma
94
461
2.11
10.02
1.3
1.2
u/ml
130.4
262.5
1.15
85
418
(3051611) Lipemic interference index of Serum or Plasma
36
110
3.33
9.89
5.4
3.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
97
489
2.06
9.62
3.4
3.1
pmol/l
4.0
4.6
5.00
87
429
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
24
56
4.34
9.60
1.5
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
69
304
2.34
9.55
1.5
1.6
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
33
98
3.43
9.48
1.4
1.2
nmol/l
0.2
0.2
—
12
9
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
33
98
3.43
9.48
1.4
1.2
nmol/l
1.4
0.6
0.88
33
93
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
73
332
2.27
9.39
1.2
1.8
u/l
35.4
40.0
1.33
59
284
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
23
6.58
9.36
1.3
1.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
51
197
2.65
9.32
1.3
1.2
u/ml
1.7
2.4
—
8
19
(3012516) Albumin [Mass/volume] in Urine
450
3444
1.45
9.16
3.6
3.2
mg/l
487.1
219.2
0.64
336
2154
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
41
143
2.92
9.07
2.9
1.9
u/ml
15.8
1876.2
0.50
41
136
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
15
24
6.31
9.00
2.6
1.3
umol/l
117.1
51.4
—
10
10
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
15
24
6.31
9.00
2.9
1.8
e6/l
47570.2
2187.2
—
10
15
(3010144) Erythrocytes [#/volume] in Synovial fluid
29
82
3.59
8.98
1.5
1.3
e6/l
658188.3
175737.4
0.85
23
54
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
58
245
2.43
8.83
1.5
1.6
iu/ml
8.5
0.3
0.46
12
48
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
50
198
2.58
8.71
1.3
1.2
u/ml
5.0
11.5
—
10
29
(3033799) Differential panel - Peritoneal fluid
15
25
6.05
8.66
4.5
2.4
—
—
—
0
0
(3025315) Body weight
10
10
10.07
8.65
8.3
5.4
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
144
857
1.76
8.63
6.8
3.4
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
18
36
5.05
8.63
1.2
1.1
ratio
1.2
1.1
—
5
12
(3024139) IgG subclass 3 [Mass/volume] in Serum
24
61
3.99
8.62
1.2
1.3
g/l
0.4
0.5
0.67
17
42
(3028192) IgG subclass 2 [Mass/volume] in Serum
24
61
3.99
8.62
1.2
1.3
g/l
2.6
3.0
0.43
17
42
(3027135) IgG subclass 1 [Mass/volume] in Serum
24
61
3.99
8.62
1.2
1.3
g/l
7.1
7.9
0.33
17
42
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
151
912
1.74
8.59
2.3
1.7
%
1.6
1.5
1.34
122
789
(3045788) Cell count panel - Pleural fluid
37
126
2.99
8.54
1.5
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
14
22
6.42
8.54
2.3
1.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
30
90
3.38
8.51
1.4
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
11
13
8.52
8.47
1.5
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
18
37
4.92
8.37
1.6
1.4
%
8.4
1.0
—
5
7
(3037756) Immunofixation for Serum or Plasma
53
222
2.44
8.23
1.6
1.5
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
35
118
3.02
8.23
3.4
3.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
52
216
2.46
8.22
1.4
1.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
37
129
2.92
8.21
2.7
1.3
mmol/l
3.9
3.7
0.40
30
121
(3018572) Chloride [Moles/volume] in Blood
56
241
2.38
8.20
7.4
5.7
mmol/l
104.1
105.3
1.08
49
211
(3039000) Anion gap in Blood
56
241
2.38
8.20
7.4
5.7
mmol/l
11.9
11.1
0.90
49
211
(4035726)
142
856
1.73
8.13
1.6
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
55
237
2.38
8.04
2.6
1.6
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
32
104
3.13
8.01
5.2
2.8
%
64.3
56.2
1.00
20
70
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
23
60
3.88
7.99
1.3
1.2
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
23
60
3.88
7.99
1.3
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
23
60
3.88
7.99
1.3
1.2
—
—
—
0
0
(3019977) pH of Arterial blood
20
47
4.30
7.95
2.2
2.2
ph
7.4
7.4
0.10
11
15
(3019150) Specific gravity of Urine by Refractometry
312
2278
1.48
7.93
4.9
3.7
kg/l
1.0
1.0
0.14
45
343
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1079
9777
1.47
7.92
7.6
6.1
mmol/mol
41.0
40.5
1.10
990
8892
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
37
132
2.85
7.89
1.1
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
42
161
2.66
7.83
1.8
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
21
52
4.09
7.81
3.8
1.5
e9/l
1.0
1.2
0.51
14
28
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
101
557
1.88
7.77
2.6
2.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
24
66
3.68
7.75
1.2
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
87
459
1.96
7.64
2.3
2.7
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
11
15
7.38
7.56
1.1
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
26
77
3.42
7.54
1.3
1.0
—
—
—
0
0
(4062490)
23
63
3.70
7.48
1.2
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
29
93
3.16
7.43
1.2
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
17
37
4.64
7.41
4.5
1.5
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
26
78
3.38
7.40
1.0
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
39
149
2.66
7.34
2.7
1.3
mg/l
501.5
486.1
0.10
34
137
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
36
132
2.77
7.32
2.8
1.4
e6/l
3.8
8.0
0.46
26
98
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
36
132
2.77
7.32
2.9
1.5
e6/l
60.7
1170.6
0.72
27
104
(3033705) Calcium.ionized [Moles/volume] in Venous blood
37
138
2.73
7.29
3.9
2.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
35
128
2.78
7.16
1.5
1.3
—
—
—
0
0
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
10
5
20.13
7.13
1.1
1.0
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
10
5
20.13
7.13
1.2
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
38
146
2.65
7.08
1.4
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
35
129
2.76
7.06
1.5
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
35
129
2.76
7.06
1.5
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
35
129
2.76
7.06
1.5
1.3
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
20
52
3.89
6.99
3.0
2.3
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
20
52
3.89
6.99
1.2
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
26
81
3.25
6.99
1.3
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
142
892
1.66
6.99
4.0
3.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
35
130
2.74
6.96
1.5
1.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
27
87
3.15
6.88
1.4
1.2
u/l
56.3
66.2
0.37
20
61
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
11
17
6.51
6.78
1.0
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
58
276
2.15
6.75
1.3
1.1
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
58
276
2.15
6.75
1.3
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
48
211
2.32
6.75
1.2
1.8
mg/l
14.0
12.1
0.50
41
192
(3000570) Elastase.pancreatic [Mass/mass] in Stool
54
251
2.20
6.67
1.5
1.5
ug/g
259.1
272.2
0.17
29
140
(3044290) Cell count panel - Cerebral spinal fluid
31
111
2.83
6.61
2.6
1.4
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
58
279
2.13
6.58
1.3
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
28
96
2.96
6.45
1.4
2.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
23
70
3.32
6.43
2.6
1.7
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
16
38
4.25
6.29
4.6
1.4
%
11.1
16.0
—
10
17
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
12
22
5.49
6.29
1.1
1.2
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
12
22
5.49
6.29
1.2
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
12
22
5.49
6.29
1.1
1.2
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
23
72
3.23
6.16
1.3
1.4
u/ml
30.4
23.2
—
5
16
(3000492) Spirometry study
129
818
1.64
6.13
1.5
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
33
128
2.62
6.07
1.5
1.3
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
26
89
2.96
6.02
2.8
2.0
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
27
95
2.88
5.96
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
18
49
3.71
5.93
1.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
18
49
3.71
5.93
1.0
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
18
49
3.71
5.93
1.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
19
54
3.55
5.89
1.3
1.1
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
11
20
5.54
5.81
1.4
1.9
—
—
—
0
0
(4198724)
11
20
5.54
5.81
1.5
1.4
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
18
50
3.63
5.77
1.0
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
18
50
3.63
5.77
2.0
1.6
u/l
13.8
5.7
0.51
11
25
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
18
50
3.63
5.77
1.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
18
50
3.63
5.77
1.0
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
12
24
5.03
5.75
1.1
1.1
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
12
24
5.03
5.75
1.5
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
20
60
3.37
5.73
1.4
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
20
60
3.37
5.73
1.4
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
75
416
1.85
5.72
1.3
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1062
9772
1.37
5.71
4.7
4.0
mmol/l
1.3
1.3
2.47
955
8683
(3023410) Appearance of Cerebral spinal fluid
18
51
3.56
5.61
4.2
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
19
56
3.43
5.59
4.6
3.4
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
7
12.93
5.58
6.4
5.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
16
42
3.84
5.54
1.4
1.3
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
16
42
3.84
5.54
1.4
1.3
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
11
21
5.27
5.53
1.7
1.5
—
—
—
0
0
(3019225) pH of Specimen
161
1105
1.52
5.45
7.1
3.9
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
8
5
16.09
5.41
1.6
1.2
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
29
112
2.62
5.41
1.5
1.5
g/l
0.8
0.9
0.05
22
85
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
16
43
3.75
5.37
2.2
2.4
%
31.0
47.4
—
7
15
(3044242) Glucose [Moles/volume] in Arterial blood
18
53
3.43
5.31
2.2
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
13
30
4.36
5.30
3.1
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
35
151
2.35
5.20
1.3
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
14
35
4.03
5.17
1.1
1.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
14
35
4.03
5.17
1.1
1.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
14
35
4.03
5.17
1.1
1.3
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
14
35
4.03
5.17
1.1
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
18
54
3.36
5.17
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
18
54
3.36
5.17
1.0
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
946
8608
1.31
5.13
51.4
17.4
g/l
327.9
332.1
28.89
940
8525
(3022621) pH of Urine by Test strip
110
703
1.61
5.09
3.0
2.8
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
41
192
2.17
5.04
1.2
1.3
miu/ml
155.7
257.6
—
10
77
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1099
10231
1.36
5.00
5.1
4.5
mmol/l
4.2
4.5
22.04
1009
9273
(1761482) Bacteria [#/volume] in Urine by Culture
58
311
1.90
4.95
8.2
3.9
—
—
—
0
0
(3036670) Protein [Mass/volume] in Synovial fluid
13
32
4.09
4.90
1.2
1.3
g/l
36.5
37.6
—
7
17
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
32
137
2.37
4.85
1.2
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
22
78
2.85
4.83
3.5
3.2
%
9.9
11.7
1.11
22
78
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1089
10141
1.34
4.81
5.1
4.4
mmol/l
1.3
1.4
10.86
981
9098
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
24
4.61
4.78
1.7
1.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
25
96
2.63
4.74
1.1
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
91
565
1.65
4.74
6.9
3.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
64
362
1.81
4.64
4.3
3.1
g/l
0.5
0.2
0.62
37
147
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
20
69
2.93
4.61
1.3
1.2
—
—
—
0
0
(4281824)
25
98
2.58
4.56
1.9
1.2
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
9
11
8.23
4.56
1.4
1.5
mu/l
584.3
369.5
—
9
11
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
9
11
8.23
4.56
1.4
1.5
%
77.2
75.1
—
9
11
(3004716) Salmonella sp identified in Stool by Organism specific culture
74
440
1.72
4.53
1.3
1.3
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
8
8
10.05
4.52
1.4
1.4
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
17
54
3.17
4.49
5.7
12.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
17
54
3.17
4.49
3.9
2.7
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1097
10265
1.33
4.41
5.4
4.7
mmol/l
6.1
6.0
1.05
982
9137
(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum
18
60
3.03
4.40
1.0
1.1
—
—
—
0
0
(4010399)
111
743
1.54
4.25
1.5
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
75
457
1.68
4.22
2.7
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
90
579
1.59
4.10
1.7
1.6
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
10
23
4.37
4.09
10.3
5.7
—
—
—
0
0
(3004451) EKG impression Narrative
16
52
3.10
4.09
1.7
1.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
14
42
3.36
4.05
2.9
3.7
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
28
124
2.28
3.98
2.0
1.5
—
—
—
0
0
(3000012) Reticulocyte production index
16
53
3.04
3.97
1.1
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
15
49
3.08
3.81
1.1
1.1
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
14
44
3.20
3.78
1.4
1.2
u/l
30.1
31.6
—
9
32
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
7
8
8.79
3.77
2.6
2.8
u/field
0.9
0.6
—
7
8
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
34
167
2.06
3.77
2.2
2.2
u/l
2716.7
2309.1
0.08
16
70
(3037556) Urate [Mass/volume] in Serum or Plasma
12
34
3.55
3.77
1.4
1.3
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
13
39
3.36
3.76
2.3
2.3
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
36
181
2.02
3.75
1.8
1.4
u/l
10.4
7.6
0.51
25
144
(3035880) pH of Pleural fluid
19
72
2.66
3.74
1.1
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1113
10511
1.30
3.65
5.7
5.1
mmol/l
2.4
2.6
20.04
1019
9460
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
11
30
3.69
3.64
1.3
1.1
u/ml
—
20.8
—
0
6
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
49
278
1.79
3.58
2.3
2.3
ug/min
231.1
112.8
0.79
31
164
(3028433) Virus identified in Specimen by Culture
10
26
3.87
3.52
1.4
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
17
5.32
3.51
1.6
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
172
1300
1.37
3.49
1.5
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
34
631
0.53
3.46
1.7
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
68
428
1.62
3.43
1.1
1.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
17
64
2.68
3.40
1.2
1.3
mmol/l
14.3
10.4
—
7
20
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
16
59
2.73
3.33
1.1
1.1
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
14
48
2.94
3.30
4.2
1.7
e6/l
471.4
693.1
—
5
19
(36660697) Celiac disease serology panel - Serum
99
685
1.48
3.29
1.2
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
15
54
2.80
3.26
2.3
1.5
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
93
638
1.49
3.23
4.4
2.9
e9/l
4.5
4.2
0.43
65
469
(3006653) Thiamine [Moles/volume] in Blood
12
38
3.18
3.21
1.2
1.1
nmol/l
128.1
136.5
0.27
12
38
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
10
28
3.59
3.20
3.8
2.3
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
10
28
3.59
3.20
9.9
24.3
nmol/l
1455.8
1709.3
—
10
28
(3014051) Protein [Presence] in Urine by Test strip
42
237
1.80
3.16
2.9
2.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
20
429
0.46
3.15
1.3
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
11
34
3.25
3.06
1.1
1.7
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
8
7.53
3.05
2.2
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
8
16
5.02
3.05
2.1
1.8
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
35
190
1.86
2.99
1.8
1.5
mu/l
359.8
283.2
0.71
29
172
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
11
35
3.16
2.93
2.4
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
9
22
4.11
2.88
10.8
5.5
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
37
208
1.80
2.84
2.4
3.0
u/ml
285.5
178.1
0.17
31
194
(21494755) Public health laboratory ask at order entry panel
35
603
0.57
2.81
1.3
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
9
23
3.93
2.77
1.4
1.1
—
—
—
0
0
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
5
6
8.36
2.75
3.4
4.0
ug/min
215.2
53.5
—
5
6
(3052592) Norovirus Ag [Presence] in Stool
8
19
4.23
2.68
1.4
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
24
3.77
2.67
1.3
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
7
15
4.68
2.60
1.6
1.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
6
11
5.47
2.54
1.5
1.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
21
101
2.10
2.53
1.1
1.3
pmol/l
454.1
260.3
1.03
16
78
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
16
69
2.33
2.49
1.4
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
16
4.39
2.47
1.1
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
7
16
4.39
2.47
1.4
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
23
117
1.98
2.41
1.1
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
12
5.02
2.40
2.0
2.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
12
5.02
2.40
2.0
2.1
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
8
6.27
2.37
1.2
1.3
ng/l
173.6
81.9
—
5
8
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
5
8
6.27
2.37
1.8
1.1
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
64
436
1.49
2.37
2.6
2.9
u/ml
95.7
80.1
0.13
59
422
(3026389) Candida sp identified in Specimen by Organism specific culture
22
111
2.00
2.36
1.6
1.2
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
12
46
2.62
2.36
2.6
3.7
nmol/l
113.3
116.3
0.02
12
46
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
7
17
4.13
2.36
1.1
1.0
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
7
17
4.13
2.36
2.3
1.6
ug/l
123.0
88.6
—
7
17
(3045424) Erythrocytes [Presence] in Urine
31
176
1.78
2.35
2.2
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
76
539
1.43
2.30
2.4
2.5
—
18.4
—
0
23
(3016018) Differential panel - Cerebral spinal fluid
14
59
2.39
2.29
2.8
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
18
85
2.13
2.29
1.7
1.9
—
—
—
0
0
(3011335) Digoxin [Mass/volume] in Serum or Plasma
6
13
4.63
2.27
2.5
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
83
601
1.41
2.24
1.2
1.2
—
—
—
0
0
(4027681)
9
29
3.12
2.22
1.0
1.2
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
5
9
5.57
2.21
1.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
19
94
2.04
2.16
1.3
1.3
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
22
115
1.93
2.16
1.1
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
7
19
3.70
2.15
1.3
1.0
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
7
19
3.70
2.15
1.3
1.0
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
34
205
1.68
2.12
1.7
1.5
iu/l
30.8
26.7
0.22
28
174
(3044007) Cell count panel - Peritoneal fluid
8
25
3.21
2.09
3.8
1.5
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
33
199
1.67
2.06
3.0
1.4
nmol/l
1.1
0.8
1.04
28
162
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
13
56
2.33
2.05
2.2
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
24
133
1.82
2.00
1.0
1.1
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
11
4.56
1.94
1.4
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
466
4200
1.17
1.94
5.1
5.3
ug/l
2.6
3.1
0.71
403
3721
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
27
2.97
1.93
1.1
1.2
iu/ml
101.1
210.9
—
8
27
(3047189) Immunofixation for 24 hour Urine
11
45
2.46
1.93
1.5
1.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
15
71
2.12
1.92
1.7
1.2
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
15
71
2.12
1.92
4.3
2.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
84
630
1.35
1.88
1.4
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
7
22
3.19
1.88
1.0
1.0
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
7
22
3.19
1.88
1.0
1.0
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
17
3.54
1.84
1.0
1.1
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
12
4.18
1.82
1.0
1.0
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
12
54
2.23
1.74
1.4
1.2
u/ml
0.2
1.0
—
7
28
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
71
528
1.36
1.70
1.2
1.2
iu/ml
113.0
149.2
0.26
19
193
(3039443) Prostate specific Ag panel - Serum or Plasma
8
179
0.44
1.69
1.6
1.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
32
204
1.58
1.66
1.2
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
6
19
3.17
1.66
1.2
1.5
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
24
142
1.70
1.65
1.0
1.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
39
262
1.50
1.62
4.7
3.3
mg/l
25.1
29.7
0.39
27
171
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
5
14
3.58
1.61
1.0
1.0
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
34
222
1.54
1.60
1.3
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
20
3.01
1.58
1.3
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
20
3.01
1.58
1.3
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
7
26
2.70
1.58
1.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
27
2.60
1.51
3.1
2.4
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
7
27
2.60
1.51
3.1
2.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
6
22
2.73
1.43
1.0
1.1
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
17
95
1.80
1.43
1.5
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
10
46
2.18
1.40
1.6
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
7
29
2.42
1.39
1.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
23
2.62
1.37
1.2
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
15
83
1.82
1.31
2.2
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
34
2.36
1.29
1.4
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
16
91
1.77
1.29
2.4
1.9
u/field
0.6
2.6
—
5
27
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
48
353
1.37
1.29
1.9
1.8
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
5
18
2.78
1.28
1.0
1.1
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
11
55
2.01
1.27
1.1
1.0
ng/l
362.4
286.4
—
5
32
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
11
56
1.97
1.22
1.1
1.0
ng/l
67.2
40.5
—
5
32
(21494814) CD8 cells/100 lymphocytes in Specimen
5
19
2.64
1.21
1.4
1.4
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
19
2.64
1.21
1.4
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
37
2.17
1.21
1.5
1.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
39
280
1.40
1.21
1.7
1.7
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
6
26
2.31
1.18
1.5
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
38
2.11
1.18
1.1
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
14
79
1.78
1.17
1.5
1.5
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
34
0.00
1.16
0.0
1.4
—
—
—
0
0
(3017704) Immunofixation for Urine
10
51
1.97
1.11
1.2
1.5
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
7
31
2.26
1.10
1.6
1.2
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
21
2.39
1.09
1.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
81
1.74
1.09
1.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
29
203
1.44
1.05
1.3
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
7
33
2.13
1.05
1.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
35
254
1.39
1.05
1.1
1.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
297
3253
0.89
1.03
3.5
2.9
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
7
34
2.06
1.03
1.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
29
205
1.42
1.01
1.9
1.6
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
107
1.60
1.00
1.2
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
29
207
1.41
0.97
1.9
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
12
69
1.75
0.96
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
29
208
1.40
0.95
1.9
1.6
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
14
85
1.65
0.94
1.2
2.3
umol/l
3.7
9.3
—
9
59
(3028679) Herpes simplex virus Ab [Presence] in Serum
6
27
2.23
0.93
1.3
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
6
27
2.23
0.93
1.3
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
6
31
1.94
0.84
1.5
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
35
266
1.32
0.83
2.5
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
11
65
1.70
0.82
1.0
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
21
295
0.71
0.82
1.6
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
26
190
1.38
0.79
1.9
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
5
24
2.09
0.74
1.0
1.5
ug/l
9.8
9.2
—
5
24
(3038177) Helicobacter pylori Ab [Presence] in Serum
16
108
1.49
0.73
1.5
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
38
1.85
0.73
1.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
30
228
1.32
0.73
1.6
1.4
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
26
194
1.35
0.71
1.8
1.6
iu/l
4.8
5.0
—
9
64
(4015189)
5
27
1.85
0.68
1.2
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
86
744
1.17
0.67
2.2
2.1
nmol/l
11.3
12.7
0.67
74
658
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
159
1437
1.12
0.66
13.3
6.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
27
207
1.31
0.64
1.9
1.6
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
17
121
1.41
0.62
1.2
1.1
u/ml
0.1
3.4
—
9
51
(44806420)
8
49
1.64
0.62
1.9
2.3
—
—
—
0
0
(4034850)
42
343
1.23
0.61
16.7
10.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
5
30
1.67
0.61
1.2
1.0
miu/ml
1373.8
1523.7
—
5
30
(3011288) Drugs identified in Urine by Screen method
19
139
1.37
0.60
1.9
2.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
8
52
1.54
0.59
1.3
1.2
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
8
52
1.54
0.59
1.0
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
20
149
1.35
0.58
1.6
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
79
690
1.15
0.57
1.8
1.9
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
72
625
1.16
0.56
1.7
1.8
—
—
—
0
0
(4024509)
14
98
1.43
0.56
1.2
1.6
—
—
—
0
0
(40768793) Breast Pathology biopsy report
16
218
0.73
0.56
1.4
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
9
63
1.43
0.52
2.3
1.4
g/l
0.9
1.0
—
9
63
(1001926) Buprenorphine [Presence] in Urine by Screen method
21
161
1.31
0.52
1.6
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
95
1059
0.89
0.50
1.4
1.6
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
10
141
0.71
0.45
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
10
141
0.71
0.45
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
10
141
0.71
0.45
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
10
141
0.71
0.45
1.5
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
15
113
1.33
0.42
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
15
114
1.32
0.40
1.1
1.1
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
17
0.00
0.40
0.0
1.5
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
106
1.32
0.39
1.1
1.1
u/ml
5.1
6.8
—
8
53
(3035933) Granulocytes/100 leukocytes in Blood
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
8
113
0.71
0.37
1.6
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
8
113
0.71
0.37
1.6
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
8
116
0.69
0.37
1.8
1.5
—
—
—
0
0
(44813793)
9
71
1.27
0.36
1.0
1.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
150
1406
1.07
0.34
5.1
4.7
%
33.4
32.8
0.21
107
885
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
11
82
1.34
0.34
2.4
2.8
u/ml
39.3
56.6
0.37
11
82
(1002224) Polysomnography panel
34
293
1.16
0.33
1.1
1.1
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
11
83
1.33
0.32
1.2
1.0
u/ml
3.5
6.1
—
5
28
(3008401) Mugwort IgE Ab [Units/volume] in Serum
13
101
1.29
0.31
1.1
1.1
u/ml
0.1
1.1
—
7
46
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
52
1.35
0.31
1.0
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
10
75
1.34
0.30
1.2
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
119
1115
1.07
0.29
1.5
1.4
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
15
121
1.24
0.28
1.1
1.1
—
14.5
—
0
7
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
121
0.74
0.27
1.7
1.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
150
0.80
0.27
1.8
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
25
289
0.86
0.26
1.1
1.2
—
—
—
0
0
(4146454)
17
141
1.21
0.26
2.1
2.7
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
19
160
1.19
0.25
2.4
1.8
pmol/l
156.2
222.0
2.01
19
149
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
17
143
1.19
0.23
1.5
2.2
mg/l
29.0
26.7
—
5
29
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
5
39
1.28
0.23
1.4
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
5
39
1.28
0.23
1.2
1.2
—
—
—
0
0
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
22.1
—
0
11
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
237
2436
0.97
0.17
3.1
3.2
ug/l
0.7
0.8
1.13
170
1675
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
286
2792
1.03
0.16
1.7
1.6
mmol/l
1.4
1.3
1.24
232
2319
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
13
111
1.17
0.15
2.2
1.7
—
—
—
0
0
(4094501)
29
265
1.10
0.14
1.1
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
20
181
1.11
0.12
1.3
1.4
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
44
1.14
0.10
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
44
1.14
0.10
1.2
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
46
1.09
0.09
1.2
1.1
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
16
173
0.92
0.06
1.4
1.5
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
10
98
1.02
0.00
1.4
1.5
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
342
3416
1.00
0.00
4.3
4.6
%
23.0
22.0
0.45
171
1763
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
26
265
0.98
0.00
1.5
1.6
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
58
0.86
0.00
1.0
1.1
—
6.2
—
0
11
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
9.8
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
92
0.98
0.00
1.9
1.2
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
61
0.98
0.00
1.3
1.1
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
5
50
1.00
0.00
13.0
6.3
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
11
110
1.00
0.00
2.8
1.8
—
—
—
0
0
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.1
—
3.5
—
0
8
(4211845)
5
54
0.93
0.00
5.6
3.3
—
—
—
0
0
(4212803)
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
13.0
—
0
5
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
9
0.00
0.00
0.0
1.0
—
29.3
—
0
9
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
5
49
1.02
0.00
5.6
3.4
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_HAEMORRHAGE_NOT_ELSEW_CLASSIFIED – Haemorrhage, not elsewhere classified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).